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ABSTRACT 
  
Ataxia telangiectasia mutated (ATM) and DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs), are DNA damage response (DDR) proteins that have well established 
roles in the repair of DNA double strand breaks (DSBs).  A growing body of scientific 
evidence suggests that these kinases have important, but not yet well-understood, immune 
and metabolic functions.  ATM and DNA-PKcs can regulate cellular oxidative stress and 
combat reactive oxygen species (ROS) (Chen et al 2012).  Since oxidative stress is a driving 
factor in the pathogenesis of many obesity related complications, ATM and DNA-PKcs 
may help respond to and regulate oxidative stress in adipocytes. 
Precise oxidative signaling is necessary for adipocyte differentiation and lipid 
accumulation.  Selenium, a nutrient with suspected insulin mimetic properties, can alter 
cellular oxidative stress (H Gandhi et al 2013).  Therefore, it is plausible that selenium may 
affect adipogenesis and change lipid accumulation patterns in cells.     
The primary research questions were as follows: What is the role of ATM and DNA-
PKcs in adipogenesis and adipocyte homeostasis?  Are the actions of these kinases in 
adipocytes explained by changes in oxidative stress levels?  Do proposed nutrients with 
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insulin mimetic properties, like selenium, affect adipogenesis via the suspected ATM - 
DNA-PKcs - ROS pathway?  
Time dependent mammalian cell culture based experiments that measured outcome 
variables like lipid accumulation, senescence activity, protein expression and ROS levels 
were conducted to assess the action of ATM and DNA-PKcs during adipogenesis and the 
effect of selenium on the ATM - DNA-PKcs – ROS dependent adipogenic pathway. 
This study found that ATM and DNA-PKcs are necessary proteins for maintaining 
adipocyte integrity as well as having a significant role in the differentiation of preadipocyte 
to adipocyte.  Furthermore, we confirmed that the kinases act via a ROS dependent 
pathway and that dietary nutrients, such as selenium, can exert additional control over this 
pathway, therefore highlighting the impact adipocyte metabolism exerts over total 
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Obesity has become a global health concern, significantly affecting populations in the 
United States and other westernized countries (James et al 2001, Malik et al 2013, Ogden 
et al 2006, Popkin and Doak 1998, Seidell 2000).  Obesity is not only a burden financially, 
emotionally, and socially, but it also predisposes individuals to a range of health problems, 
such as type 2 diabetes, metabolic syndrome, cardiovascular disease and hypertension, 
which are comorbidities frequently associated with obesity (Kelly et al 2008, Kress et al 
2005, Must et al 1999, Thompson and Wolf 2001, Wang and Dietz 2002).  The molecular 
mechanisms that explain how obesity is a causative agent in many disease states remain 
largely unclear.  However, it is known that adipose tissue becomes dysfunctional with 
increasing adiposity (Guilherme et al 2008) and it is evident that the adipocyte unit itself 
is an indicator of metabolic health.  Thus, the key to understanding obesity-associated 
metabolic diseases lies in the study of adipose tissue and adipocytes (Efrat et al 2013, Moest 
et al 2013). 
We chose to conduct experiments to help elucidate adipose tissue dysfunction by 
studying the role of the PI(3)K serine/threonine kinases, ataxia telangiectasia mutated 
(ATM) and DNA-dependent protein kinase catalytic subunit (DNA-PKcs) during 
adipogenesis.  We hope our research helps to highlight the importance of oxidative tone as 





 The following explains how this dissertation is organized.  Chapter 1 consists of a 
literature review that explains in detail the ATM and DNA-PK kinases, their role in the 
DNA damage response and provides ample evidence to support our hypothesis of their 
involvement in adipogenesis.  An overview of adipose tissue biology, the differentiation 
process, the function of mature adipocytes and a close-up look at adipocyte physiology that 
focuses on lipid droplets & adipocyte remodeling is also included in the Chapter 1.  The 
literature review concludes with an in depth explanation of metabolic dysfunctions and a 
summary on how the origins of dysfunctions stem from disturbances in adipose tissue 
dysfunction.   
Chapter 2 and 3 are prepared in the style of a manuscript for publication.  Chapter 2 
is an inquiry into the role of ATM and DNA-PK during adipogenesis.  Chapter 3 builds on 
the critical interpretations and conclusions from Chapter 2 by using selenium to disturb the 
ROS-ATM-DNA-PK pathway.  Chapter 4 advances a summary of the research and 
discusses the conclusions of the dissertation.  The last sections are the appendix followed 





CHAPTER 1: REVIEW OF LITERATURE  
The PIKK Family of DNA Damage Response Proteins: ATM and DNA-
PKcs 
The DNA damage response & DNA double strand breaks 
Mammalian cells have evolutionary conserved DNA damage response pathways that 
serve to relay, amplify and translate the DNA damage signal and to coordinate cell cycle 
arrest and subsequent DNA repair (Zhou and Elledge 2000). The DNA damage response 
pathway is orchestrated by members of the PI(3)K- like protein kinases (PIKKs) family of 
proteins, which are recruited to the sites of DNA damage.  DNA damage is a causative 
agent in many disease states, such as cancer (Martin et al 2011).  Persistent DNA damage 
is thought to be an underlying mechanism in aging and age-related diseases (Karanjawala 
and Lieber 2004, Schumacher et al 2008).   
Furthermore, there are many diseases, both inherited and lifestyle attributable, which 
are associated with DNA damage and/or defective DNA repair (For a review, please see 
ref. (O'Driscoll 2012)).  In most cases, DNA damage is caused by ROS, which can originate 
from both exogenous and endogenous sources (Sirbu and Cortez 2013).  An example of 
ROS originating from an exogenous source is the ROS generated via ionizing radiation 
(Leach et al 2001).  The byproducts of oxidative phosphorylation are an endogenous 




DNA double strand breaks 
DNA double strand breaks (DSBs), a particularly harmful type of DNA lesion (Lees-
Miller et al 1990), can be created after DNA damage, but also can be a consequence of 
replication failure (Pardo et al 2009). The proper repair of DSBs is critical for genomic 
stability in order to prevent cancer and delay aging.  Following the creation of a DSB, the 
PIKK family members ATM and DNA-PKcs are activated then initiate the DNA damage 
response.  These proteins recognize the DNA lesions and initiate downstream processes 
that relay and amplify the damage signal (Shrivastav et al 2009).  After appropriate 
signaling and amplification, effector proteins are activated, which modulate the cell cycle, 
reconstruct chromatin and control DNA repair (Khanna and Jackson 2001).  For detailed 
reviews on the DNA damage response and DSB repair, please see refs.  (Lees-Miller and 
Meek 2003, Sirbu and Cortez 2013, Vignard et al 2013). 
 Ataxia- telangiectasia mutated (ATM) 
The Atm gene is responsible for encoding ATM protein kinase, whose best-known 
function is as the main activator of the DNA damage response following the formation of 
DNA DSBs (Shiloh and Ziv 2013).  The ATM protein is primarily found in the nucleus 
and is necessary for a proper DNA damage response (Lavin 2008).  Recently, ATM was 
shown to be activated by oxidative stress without the presence of DNA DSBs (Ditch and 
Paull 2012, Guo et al 2010a, Guo et al 2010b).  ATM is likely to have a role in regulating 
oxidative stress independent of, and in addition to, its role in DNA DSB repair.  The role 
of ATM has been further expanded after research shows that it has a critical role in immune 





Mutations in ATM cause the disease ataxia- telangiectasia (A-T), which is a premature 
aging syndrome characterized by ataxia and ocular telangiectasia (Huang, et al. 2013).  
Interestingly, more than 500 mutations are known to cause the disease, with the severity of 
the disease depending on the location and type of mutation.  Approximately 75% of Atm 
mutations are frameshifts or nonsense mutations (Concannon and Gatti 1997, Wright et al 
1996), which truncate the entire protein.  Other mutations, such as missense mutations or 
errors in splicing, can result in genomic duplication or deletion.   
There is emerging evidence that strongly supports a role of ATM in metabolism 
outside of its role in the DNA damage response (Shiloh and Ziv 2013, Stagni et al 2013, 
Stracker et al 2013).  Although the DNA damage response function of ATM is carried out 
in the nucleus, there is a considerable concentration of cytoplasmic ATM that are capable 
of binding proteins involved in cellular transport (Alexander and Walker 2010, Boehrs et 
al 2007, Lim et al 1998, Rotman and Shiloh 1999).  In addition to their neurological 
symptoms,  A-T patients also have higher incidences of developing type 2 diabetes, insulin 
resistance (Bar et al 1978), adipocyte lipotoxicity, mitochondrial dysfunction and also have 
increased systemic oxidative stress (Blevins and Gebhart 1996, Ersoy et al 1991, Lavin and 
Shiloh 1997, Morrell et al 1986, Schalch et al 1970). Many growth abnormalities and 
problems with cellular homeostasis in A-T patients cannot be explained by defective DNA 
damage repair alone.  Most A-T patients do not have diabetes, but this may be because they 
do not live long enough to develop the disease.  In one study, 10 out of 17 A-T patients 





ATM is insulin responsive (Ching et al 2013, Yang and Kastan 2000); and its kinase 
activity is responsible for the insulin stimulated phosphorylation of Akt/Protein Kinase B 
(a key insulin signaling protein intermediate) at serine 473 after insulin treatment (Halaby 
et al 2008).  Furthermore, a downstream target of ATM, p53, is involved in several stress 
signaling pathways that can influence metabolic and glucose homeostasis (Armata et al 
2010).  For example, one of the well-characterized masters of cellular metabolism the 
mammalian target of rapamycin (mTOR) is inhibited by p53 activation (For a review of 
p53 & metabolic regulation please see refs. (Armata, et al. 2010, Berkers et al 2013)).   
Glucose transport into cells is often impaired in people with type 2 diabetes and causes 
reduced glucose clearance, leading to hyperglycemia. ATM plays a role in glucose 
transport in cultured cells; ATM mutant myoblasts display decreased glucose transport.  
Glucose transporter 1 (GLUT1)(Andrisse et al 2013) is responsible for the physiologically 
relevant portion of basal glucose transport, contains a phosphorylation site specific for the 
ATM kinase.  Phosphorylation of Serine 490 of GLUT1 is critical for GLUT1-mediated 
glucose uptake.  Specifically, ATM kinase chemical inhibition diminishes basal glucose 
transport and that ATM kinase activity is necessary to phosphorylate Serine 490, which 
when taken together, suggests that ATM is needed for GLUT1 cell surface localization and 
subsequent glucose uptake.  Furthermore, the chemical inhibition of ATM decreases the 
rate at which it is recycled to the cell surface, suggesting that GLUT1 is in fact an in vivo 
ATM substrate. Interestingly, ROS formation can down regulate glucose transporter 
expression and promote insulin resistance in mature adipocytes (Kozlovsky et al 1997, 





The GoDarts study in 2011 found that individual variation in the Atm gene was shown 
to alter the glycemic response to the common diabetic drug metformin (GoDarts et al 
2011).  Specifically, those with the single nucleotide polymorphism rs11212617, at a locus 
containing the Atm gene, had better treatment success with metformin.  Furthermore, the 
group provided mechanistic evidence to suggest the possible mechanistic underpinnings of 
their observations.  Firstly, they chose to study AMP-activated protein kinase (AMPK), 
because it is the pharmacological target of the insulin sensitizing drug metformin.  
Although the exact mechanism is unclear, metformin does activate AMPK by inhibiting 
the mitochondrial respiratory chain (Zhou et al 2001).  Inhibiting the mitochondrial 
respiratory chain increases cellular AMP, which is widely considered to be the mechanism 
responsible for metformin’s insulin sensitizing benefits. 
The GoDarts researchers treated rat H4IIE hepatoma cells with the selective ATM 
kinase inhibitor KU 55933 and found that the activation of AMPK by metformin was 
significantly reduced.  To confirm further their genome wide association study data, they 
studied the activation of the well-characterized marker of AMPK activation, Serine 79 of 
Acetyl-CoA carboxylase.  Western blot analysis showed that after KU 55933 treatment, 
phosphorylation of Acetyl-CoA carboxylase was significantly decreased. 
 Due to the novelty of the GoDarts study, three separate research groups responded to 
the original article.  Woods and her colleagues provided data that showed that when cells 
were treated with other ATM chemical inhibitors, such as caffeine, that there was no 
decrease in metformin induced AMPK activation, suggesting that KU 55933 reduces 
AMPK activity independent of inhibiting ATM kinase (Woods et al 2012).  Another group 




cellular uptake of metformin by reducing organic cation transporter 1, which is necessary 
for metformin uptake in cells (Yee et al 2012).  
Furthermore, the same researchers argue that the structure of KU 55933 makes it 
likely an inhibitor of organic cation transporter 1, which offers another plausible 
explanation of the cell culture data from the GoDarts study.  We also can point out alternate 
hypothesis based on the findings of the genome wide association data.  Since ATM is 
involved in GLUT4 translocation (Halaby, et al. 2008), and metformin increases fatty acid 
oxidation and GLUT4 phosphorylation (Collier et al 2006), perhaps the association 
between the particular locus and the varying responses to metformin can be explained by 
the necessity of the ATM kinase in GLUT4 phosphorylation.  
The authors of the original publication responded to their critics by defending their 
rationale for choosing ATM as the likely gene candidate at that locus (Zhou et al 2012).  
They further cited the human, mouse and cell studies that indicated ATM is likely involved 
in insulin signaling and glucose metabolism.  They also state the interpretation of their cell 
culture data cannot be used to assert that ATM is the casual gene with absolute certainty.  
However, none of the data from the groups responding to the article provides evidence to 
1) exclude ATM as the candidate gene or 2) support that other genes at the locus are in fact 
the causal genes.  The GoDarts study and the corresponding letters to the editor emphasize 
that genome wide association studies are powerful tools, but highlight the necessity of 
testing all possible gene candidates with equal rigor and without prejudice.   
Despite conflicting data relating ATM to a role in metabolic function, we believe that 




determine the contribution of ATM to metabolic processes associated with adipogenesis 
and lipid droplet formation. 
DNA-dependent protein kinase (DNA-PK)  
Recently, new roles for DNA-PK have been proposed (Chen, et al. 2012, Kong et al 
2011, Lin et al 2013, Wong and Sul 2009) that expand beyond its well characterized role 
in repairing DNA DSBs via the non-homologous end-joining pathway (NHEJ) (Burma et 
al 2006, Taleei and Nikjoo 2013).    We have found DNA-PK is a necessary intermediate 
in the senescence response following selenium exposure (Rocourt et al 2012, Wu et al 
2010) and others have shown that DNA-PK is activated during hypoxia (Bouquet et al 
2011), which is a common phenomenon associated with obesity (Trayhurn 2013, L Zhang 
et al 2011).  
The Sul lab has demonstrated a relationship between DNA-PK and insulin signaling 
(Wong et al 2009).  Specifically, they found that after activation of protein phosphatase 1 
(PP1) by insulin, PP1 then dephosphorylates DNA-PKcs, which activates DNA-PK kinase 
function.  Activated DNA-PK then phosphorylates upstream stimulatory factor 1 (USF-1) 
at Serine 262.  USF-1 is a transcription factor that controls genes related to lipogenesis, 
such as fatty acid synthase which converts glucose to fatty acids.  The group determined 
that de novo lipogenesis and activation of lipogenic genes are decreased in a DNA-PK 
deficient severe combined immune deficiency mouse model.  Furthermore, the DNA-PK 
deficient severe combined immune deficient mice also have lower plasma lipids and 
adiposity than the control mice.  Taken together, this model suggests that overfeeding 




activate it by phosphorylation.  Once activated, DNA-PK can regulate genes for lipolysis 
and lipogenesis to change the way the body stores and uses fat.   
Adipose Tissue and Adipocytes 
Differentiation 
Adipocytes and their precursors (preadipocytes) are renewed in the body in a tightly 
controlled fashion.   In adults with a healthy body mass index (BMI), the number of total 
adipocytes remains constant throughout life (Boroumand et al 1980, Roche 1981).  In order 
for a preadipocyte to become a mature adipocyte, exposure to a well-characterized and 
highly ordered sequence of hormones that promote lipid accumulation is required.  Adipose 
tissue is predominantly composed of mature adipocytes.  However, there are other cell 
types present in adipose tissue that are necessary for its proper function such as 
preadipocytes, connective tissue cells, and immune cells.   
Insulin, glucocorticoids and phosphodiesterase inhibitors activate receptor mediated 
signaling cascades that are involved in adipogenesis whereby transcriptional regulation 
changes preadipocytes into adipocytes.  After hormonal stimulation of the preadipocyte, 
transcription factors that regulate transcription of adipocyte specific genes, such as 
peroxisome proliferator-activated receptor gamma (PPARγ) and CCAAT/enhancer 
binding protein α (C/EBPα), coordinate cell proliferation, inflammatory responses and 
regulate insulin sensitivity (Choy and Derynck 2003, Kliewer et al 1995, Siersbaek et al 
2010).  There is an equally impressive body of studies that identify agents that inhibit 
adipogenesis such as the cytokines interleukin 1 (IL-1) and TNF-α, cell surface proteins, 




1998).  Thus, the induction and inhibition of adipogenesis from preadipocyte to adipocyte 
is subject to tight regulation.  The replacement of aged and damaged adipocytes is also 
tightly regulated, and these functions must remain in balance in order to supply energy 









One of the most commonly used cellular models to study adipogenesis are murine 
3T3-L1 cells.  3T3-L1 cells are considered fibroblasts until 2 days after they have reached 
100% confluency.  At this point, the cells are exposed to a hormonal cocktail of insulin, 
dexamethasone (Dex), and isobutylmethylxanthine (IBMX) in media supplemented with 
fetal bovine serum (FBS) to stimulate differentiation (Kuri-Harcuch and Castro-
Munozledo 1984).  In vitro, the hormonal regimen causes the cells to undergo an additional 
1-2 rounds of cell division, termed clonal expansion, after which key transcription factors 
such as PPARγ and C/EBPα are activated (Brun et al 1996).  These two transcription 
factors then interact with cyclin-dependent kinase inhibitors and co-activators, such as the 
p160 family proteins and CBP/p300.  The proteins then assist with transactivation and 
promote adipogenesis (Rosen and MacDougald 2006).  Often times, the co-activators 
possess chromatin-remodeling ability, such as histone acetyltransferase activity.   
The full understanding of the induction of the transcription factors is unclear; 
however, after up-regulation of these genes, preadipocytes undergo a final permanent 
growth arrest and are now committed to the adipocyte lineage.  From this point, the cells 
are referred to adipocytes, although they are still undergoing changes that will lead to the 
fully differentiated phenotype of a mature adipocyte.  This will happen as soon as 10 days 
after hormonal stimulation.  Once differentiated, mature adipocytes are terminally 
differentiated and thought to be incapable of cell division (Findeisen et al 2011, Hallenborg 





A primary function of adipocytes, with an approximate lifespan of 10 years, is to serve 
as reservoir of energy in the form of triacylglycerol and to supply non-esterified fatty acids 
to the body as needed. Adipose tissue plays a role in cushioning and protecting our internal 
organs as well.  Brown adipose tissue is present mainly in infants and hibernating mammals 
and functions to generate body heat (Cannon and Nedergaard 2004), unlike white adipose 
tissue, which is non-thermogenic.  In humans, it is difficult to detect depots of brown fat 
past 1-2 years of age (Knittle et al 1979, McDonald and Horwitz 1999).  Furthermore, 
brown adipose tissue has little to do with the development of excess body fat in adults.  
Therefore, only white adipose tissue is associated with the accumulation of excess body 
fat, and thus the focus of our research.   
In the 1980s, the incorrect assumption was made that adipocytes were merely depots 
in which to store fat.  It is now known adipose tissue is highly complex, immune regulating, 
metabolically active organ that is necessary to sustain life (Trayhurn and Beattie 2001).  
We need adipocytes to produce hormones such as resistin, estrogen, leptin, adiponectin, 
interleukin 6 (IL-6), estradiol, plasminogen activator inhibitor-1 and TNF-α among others 
(Beltowski 2003, Trayhurn 2001, Trayhurn and Wood 2004).   
Ideally, adipocytes are performing their function correctly which is storing  
(lipogenesis) and releasing fat (lipolysis) as necessary to meet the demands of the 
individual, while remaining constant in size (Arner et al 2011).  The pathways regulating 
lipolysis and lipogenesis depend heavily on genetic and environmental factors (Brasaemle 
2007).  Lipoprotein lipase, located on the endothelial surface of adipocytes, is a triglyceride 




hydrolyzation by lipoprotein lipase.  The free fatty acids (FFAs) are reassembled into 
triglycerides (TG) in the adipocyte by esterifying the FFAs onto a glycerol molecule.  
Feeding and fasting conditions determine how fast adipocytes will uptake lipids.  When 
newly recruited adipocytes are in the presence of excess feeding, they grow at a higher rate 
than adipocytes exposed to normal conditions.  Therefore, under high energy conditions, 
newly formed adipocytes can reach their threshold sooner, possibly contributing to some 
types of metabolic dysfunction (Wellen and Hotamisligil 2003).   
Adipocytes are highly dynamic and constantly shuttle lipids between various adipose 
tissue depots throughout the body (Casteilla et al 2005).  The process of how adipose tissue 
uptakes lipids and redistributes them throughout the body in times of need is not fully 
understood, however their function is critical in maintaining energy homeostasis and whole 
body insulin sensitivity.  Unfortunately, this process is difficult to study because adipocytes 
are highly dynamic, constantly redistributing TG as well as regenerating and recycling their 
own adipocyte pool (Spalding et al 2008).  A major component of the mobilization of FFAs 
from adipose TG stores are the enzymes adipose tissue triacylglycerol lipase and hormone 
sensitive lipase that account for most of the hydrolase activity in adipose tissue (Brasaemle 
2007).  Specifically, these enzymes hydrolyze TGs to produce FFAs and glycerol that are 
released from the adipocyte to meet the metabolic demands of the individual (Reshef et al 
2003).     
Adipocytes can fluctuate in size and vary in metabolism over their lifespan (YH Lee 
et al 2013) depending on a wide variety of factors such as; age, feeding status, growth 
cycle, cytokines production, gender and nutritional status (Berthiaume et al 2004, Bourlier 




2007, Suga et al 2009, Wilson-Fritch et al 2004). Hormone levels play a large role in the 
regulation of adipocyte size (Carmean et al 2013, Havel 2004).  For example, 
glucocorticoids such as 11-beta hydroxysteroid dehydrogenase 1 promote fat deposition 
(MJ Lee et al 2013), while other hormones, like adiponectin can, confer insulin sensitivity 
and lower FFAs and TGs (Berg et al 2002).   
Lipid droplets 
Lipid droplets are cellular lipid storage organelles that are the preferred reservoir of 
TG storage (Walther and Farese 2012).  Because lipid droplets are central to energy 
homeostasis, their function and structure have been elucidated as critical factors in the 
development of metabolic disease (Konige et al 2013).    Lipid droplets confer protection 
and provide a high degree of organization for TG storage (Paar et al 2012).  Lipids that 
accumulate extracellularly or ectopically are often associated with lipid metabolism 
dysfunction (Mlinar and Marc 2011, Previs et al 2013). In white adipose tissue, lipid 
droplets begin small and then coalesce into a fewer larger droplets over time (Z Sun et al 
2013).  In fact, most mature adipocytes have only a single lipid droplet that occupies around 
90 percent of its volume (Fujimoto and Parton 2011).   Lipid droplets found in other tissues 
are usually less than 1 μm in diameter.  In tissues affected by metabolic disturbances, such 
as the liver during hepatic steatosis, the size of a lipid droplet can be up to 10 µm (Reue 
2011).  To see a representative photo of a differentiated 3T3-L1 adipocyte, refer to Figure 





Figure 2: Lipid accumulation in 3T3-L1 adipocytes 
Example of 3T3-L1 adipocytes, differentiated as indicated above, viewed under a light microscope at 400x.  Round droplets inside cells are triglycerides.  Note that not all fibroblast 




Individual lipid droplets are covered in proteins that serve metabolic and structural 
functions (Smith and Ordovas 2012).  The proteins provide lipid droplets with their only 
form of mobility within the cell. The first lipid droplet associated proteins that were 
identified were perilipins (Greenberg et al 1991), and they serve to help store and release 
of TG from the lipid droplets (Brasaemle 2007, Granneman et al 2011, Tai and Ordovas 
2007, Xu et al 2006).  Phosphorylation of perilipins is essential for hormone sensitive lipase 
translocation to the surface lipid droplet, which is a key factor in stimulating lipolysis 
(Londos et al 2005).  Perilipin under- or over- expression has the potential to promote lipid 
storage disorders and metabolic disturbances, such as lipodystrophy (Wang et al 2011).   
Other proteins associated with lipid droplets are various enzymes involved in 
triacylglycerol and phospholipid biosynthesis (Brasaemle 2007, Konige, et al. 2013).  Such 
example are: acyl-CoA diacylglycerol acyltransferases, which catalyze the formation of 
TG from diacylglycerol and acyl CoA; acyl-CoA synthetase enzymes, which are required 
for fatty acid catabolism & remodeling of membranes; and phosphocholine 
cytidylyltransferase, which is the rate controlling enzyme in the phosphatidylcholine 
biosynthesis pathway during de novo lipid synthesis.   
Adipose Tissue Plasticity  
Preadipocytes as multipotent stem cells 
Adipocytes are metabolically and phenotypically distinct from preadipocytes (Sorisky 
1999). Mature adipocytes are terminally differentiated, express lipogenic genes, have 
extensive lipid accumulation and respond to hormonal signals such as insulin (Hauner et 




their environment and have key roles in adipose tissue maintenance, beyond their role in 
serving as adipocyte precursors (Meijer et al 2011).  Preadipocytes are multipotent and 
have the potential, given the right hormonal signaling, to become osteoblasts, endothelial 
cells, myoblasts, chondrocytes and several other cell types (Miranville et al 2004, Zuk 
2001, Zuk et al 2002).  The number of preadipocytes that are able to differentiate 
successfully into mature adipocytes is dependent on the BMI of the individual and the size 
of the adipocyte (Sorisky et al 2013).  The larger the BMI and size of the adipocyte, the 
less likely preadipocytes are to differentiate (Kelly, et al. 2008).   
Proinflammatory cytokines such as TNF-α, IL-6, transforming growth factor and 
interferon-γ can inhibit preadipocyte differentiation; however, the precise mechanisms of 
how they affect adipocyte differentiation remains unclear (Tchkonia et al 2010).  Beyond 
being immature adipocytes, preadipocytes have important immune modulating functions 
(Cousin et al 1999, Isakson et al 2009, Sorisky, et al. 2013).  For example, plasma IL-6, a 
cytokine associated with aging, is produced by preadipocytes (Mohamed-Ali et al 1997).  
Furthermore, preadipocytes express known immune cell markers CD11 and CD68, which 
are associated with an inflammatory response (Trayhurn and Wood 2004, Zeyda and 
Stulnig 2007).   
Preadipocytes can behave similarly to macrophages and have analogous functions, 
such as making chemokines and engulfing bacteria (Tchkonia, et al. 2010).  Preadipocytes 
from obese individuals do not behave like typical adipocyte precursors when co-cultured 
with TNF-α, but instead express a proinflammatory macrophage-like phenotype (Isakson, 
et al. 2009).  Due to the macrophage-like state of preadipocytes from obese individuals, 




al 2003), it is probable that many adipose precursor cells are be unable to undergo 
adipogenesis.  This could cause decreased lipid accumulation capacity, thus setting the 
foundation for lipid storage diseases and promoting adipocyte tissue dysfunction (Moest, 
et al. 2013). 
Adipose tissue remodeling 
Adipose tissue remodeling is a hot topic for obesity researchers, but research has 
generated more questions than answers (Arner, et al. 2011).  A better understanding exists 
for the mechanisms causing adipocyte differentiation than the mechanisms responsible for 
maintaining adipocytes throughout their lifespan (Erener et al 2012, Hallenborg, et al. 
2012, Hou et al 2012, Tchkonia et al 2007).   It is estimated that around 10% of all 
adipocytes in adults are replaced every year, independent of the individual’s age and BMI 
(Spalding, et al. 2008).  It has yet to be determined if adipocyte size is related to the age of 
the adipocyte (Faust et al 1978, Obst et al 1981).   
Adipocytes, like other terminally differentiated cells, are comparatively long-lived 
and more resistant to cell death (Strissel, et al. 2007).  However, during obesity there is an 
increase in adipocyte necrosis, death and senescence which is associated with an increase 
in macrophage and immune cell infiltration (Lafontan 2013). The necrotic tissue is 
characterized by the formation of macrophage syncytia and the increased expression of 
proinflammatory cytokines (Cinti et al 2005). Adipocytes have an upper size limit and 
cannot continue to increase their size indefinitely under positive energy balance.  Large 
adipocytes that are incapable of storing more fat are fragile and undergo cell death or 




  Large adipocytes can be metabolically distinct from small adipocytes (Jo et al 2009, 
Skurk et al 2007).  It is unclear, and somewhat controversial, if size offers any advantage 
especially given the metabolic differences and functions of various adipose depots 
(subcutaneous fat vs. visceral fat or white adipose tissue vs. brown adipose tissue).  Obese 
individuals that remain insulin sensitive have smaller adipocytes and less macrophages in 
their adipose tissue, particularly in their subcutaneous depot, than compared to obese 
individuals who are insulin resistant controls, (Molgat et al 2011).  Thus, the dynamics 
regulating adipocyte cells involves several organs and body systems (LK Meyer et al 
2013). 
  In the case of overfeeding, it is possible that preadipocytes do not or cannot normally 
replicate, especially since the cellular dynamics controlling differentiation are adipose 
depot dependent.  For example, visceral and subcutaneous adipose depots have different 
differentiation responses to the similar environmental stimuli (Tchoukalova et al 2010).  If 
the preadipocyte pool only undergoes partial adipogenesis, it will resulting in a non-
functional, immature adipocytes that are likely to increase local and systemic 
inflammation.   
Under fasting conditions, fat can be mobilized for fuel by lipolysis.  During lipolysis, 
the stored TG in the adipocyte is hydrolyzes and it causes the adipocyte to shrink.  
Conversely, during times of excess, adipose tissue can expand by storing more TG.  There 
are physical limitations to storing TG in adipocytes.  When adipocytes are forced to 
replicate due to extreme conditions, they do so with many errors, giving rise to 
malfunctioning adipocytes or promote ectopic lipid accumulation (Girousse and Langin 




Hypertrophy and hyperplasia 
The expansion of adipose tissue can be due to hypertrophy, an increase in the 
adipocyte size, hyperplasia, an increase in adipocyte number, or both (Jo, et al. 2009).  
Factors affecting hyperplasia and/or hypertrophy are the individual’s genes, age, gender, 
environment, total body fat percentage, nutritional status (total calories vs. macronutrient 
breakdown) and the adipose depot origin (subcutaneous, visceral etc.) among others.  It is 
likely that hypertrophic and hyperplastic cells exist together in dysfunctional adipose 
tissue, and both create conditions that favor the propagation of the other.  If this is the case, 
hypertrophic and hyperplastic adipocytes contribute to the toxic cellular environment that 
is present in many diseases associated with obesity.  
Hyperplasia occurs when adipocytes are unable to take up any more TG, inducing the 
creation of new adipocytes from adipose cell precursors in the mesenchymal stem cell pool.  
It is thought hypertrophic adipocytes are inefficient for storing or releasing energy, which 
creates an environment that promotes hyperplasia.  Therefore, hypertrophy affects not only 
the enlarged cells themselves, but create a toxic environment and promote dysfunction in 
neighboring cells (Sun et al 2012).   
During obesity, the rate of lipolysis is proportional to the adipocyte’s size, with larger 
adipocytes having increased rates of lipolysis (Wueest et al 2009).  The size of the 
adipocyte may correlated with the extent of insulin resistance and other pathologies 
associated with obesity.  Hypertrophic adipocytes are thought to secrete proinflammatory 
factors, which could explain why hypertrophic adipocytes are associated with a risk of type 
2 diabetes (Yang, et al. 2012).  Neither hypertrophy nor hyperplasia are ideal (Hanamoto 




maintain equilibrium and to determine if adipose expansion causes or contributes to 
adipocyte dysfunction.  However, there are obvious difficulties with gathering this data 
because real time monitoring of individual adipocytes for a sufficient amount of time in 
vivo is not feasible at this point (Day 1999).  
Metabolic Dysfunctions 
Obesity 
Obesity can be simply defined as a BMI greater than 30 kilograms/meters squared.  
Because of the complex and highly regulated signaling pathways within the body that 
control metabolism, obesity is highly resistant to treatment (Ahima 2006, Fonseca-Alaniz 
et al 2007, Galic et al 2010, Mohamed-Ali et al 1998).  Usually obesity results from an 
overabundance of white adipose tissue (WAT).  The overabundance of WAT can stem 
either from an increased number of adipocytes storing fat or from larger adipocytes that 
continue to store more fat (Spalding, et al. 2008).  Obese individuals usually have an 
increased risk of chronic disease, however not all of the risk can be attributed to an increase 
in WAT (Ahima and Lazar 2013). Obesity is a causative agent in various metabolic 
syndromes, in part due to the increased oxidative stress burden (Berkemeyer 2010).  
Oxidative stress is known to promote inflammation and vice versa (Bondia-Pons et al 2012, 
Fernandez-Sanchez et al 2011), but it was unknown until recently that fat accumulation is 
correlated with systemic oxidative stress in humans (Furukawa et al 2004).  Regardless of 
the origins underlying the inflammatory state, infiltration by macrophages and other 
immune cells further burden adipose tissue promoting insulin resistance (Calabro and Yeh 




During obesity, adipocytes can become dysfunctional.  These hallmarks of adipocyte 
dysfunction are increased lipolysis, abnormal cytokine secretion, increased insulin 
resistance and impairments in triglyceride storage (Guilherme, et al. 2008, Hotamisligil et 
al 1995, Weisberg, et al. 2003). Furthermore, dysfunctional adipose tissue will attract 
macrophages and promote an inflammatory state (O'Rourke et al 2012, Trayhurn and 
Wood 2004).  Obese individuals with high levels of FFAs may undergo extreme 
lipogenesis in attempts to store the FFAs (McGarry and Dobbins 1999).  However, this 
will disturb homeostasis, encourage lipodystrophy and cause adipocyte dysfunction 
(Arner, et al. 2011).   
Dysfunctions in lipogenesis and lipolysis can promote various lipodystrophies 
(Vigouroux et al 2011) and greatly increase the risk of lipotoxicity.  Lipotoxicity causes 
excess fat accumulation in non-adipose tissue such as skeletal muscles, liver, heart, 
pancreatic beta-cells and kidneys (McGarry and Dobbins 1999, Unger 1995).  Obesity and 
the related comorbidities are associated with lipotoxicity, and overfeeding increases levels 
of FFAs which dramatically increases lipogenesis in attempts to lower plasma FFAs by 
shuttling them into adipocytes (McGarry and Dobbins 1999).  In dysfunctional adipose 
tissue lipotoxicity can; increase ROS causing beta-cell deterioration (Lenzen 2008), disturb 
mitochondrial homeostasis (Schrauwen and Hesselink 2004, Supale et al 2012),  promote 
nonalcoholic steatohepatitis (Cusi 2012) and impair insulin sensitivity (Vigouroux, et al. 




Type 2 diabetes  
Type 2 diabetes is characterized by insulin resistance and typically develops over a 
period of many years (Stumvoll et al 2005).  Insulin resistance is the inability of insulin 
sensitive cells to utilize glucose correctly (Ye 2013), usually due to the defects in the 
insulin-signaling pathway.  During the initial stages of insulin resistance, the pancreatic 
beta-cells will continuously produce insulin in response to hyperglycemia.  However, the 
beta-cells will eventually reach a critical point at which they can no longer sustain insulin 
production.  This is believed to be one of the most important factors that precipitate the 
onset of type 2 diabetes (Eberle et al 2013).   
The formal diagnosis of type 2 diabetes (Alberti and Zimmet 1998) occurs when 
fasting blood glucose levels are greater than 125 mg/dL, but the exact event or process that 
tips the scale from insulin resistance to diabetes is harder to determine and predict.  There 
are many factors that affect this process in individuals (Stumvoll, et al. 2005), and that is 
why we are attempting to elucidate the processes that lead to the progression of insulin 
resistance and type 2 diabetes by studying how the key proteins, ATM and DNA-PK, 
regulate oxidative tone during adipogenesis.   
Cellular senescence 
Normal somatic cells undergo senescence after they reach their proliferative capacity 
(Goldstein 1990), which is tissue specific.  Senescence is the loss of proliferative potential, 
not permanent cell cycle arrest because cells can undergo cell cycle arrest without being 
senescent (Blagosklonny 2011). Senescent cells are still metabolically active and can carry 




arrest is termed replicative senescence, during which the cells appear flat.  Senescence 
promotes aging, but is also a barrier of tumorigenesis, stifling cancer at an early stage (Patil 
et al 2005).  At a pH of 4.5- 6.0, senescence-associated β-galactosidase activity can be 
detected in senescent cells.  The reason for increased senescence-associated β-
galactosidase activity in senescent cells is due to the β-galactosidase originating from the 
lysosomes.  During senescence, there is an increase in the size and number of lysosomes. 
β-galactosidase activity is an outcome of senescence, but the activity of the enzyme is not 
required for the induction of senescence (Lee et al 2006).  
In the field of DNA damage repair and cancer, the cellular senescent phenotype is 
well studied (Campisi 2011); however, we are interested in the effects of senescence in 
adipose tissue. Principally, we are interested in the mechanisms that control preadipocyte 
senescence, which we believe to be a factor contributing to dysfunctional adipose tissue.  
Emerging lines of evidence show that differentiated adipocytes in fat tissue display 
senescent-like characteristics, challenging the basic concepts of cellular senescence 
(Tchkonia, et al. 2010).  Under oxidative stress, adipocytes exhibit a 
senescent/proinflammatory phenotype characterized by increased production of ROS, 
more DNA damage, shortened telomeres and impaired glucose uptake (Monickaraj et al 
2013). Interestingly, removal of senescent cells delays age related pathologies in various 
tissues in mice (Baker et al 2011). Thus, prevention, elimination or treatment of senescent 
cells in adipose tissue is a possible therapeutic intervention for the treatment of the 





The age related changes in adipose tissue of obese individuals, whether they are young 
or old, may have severe systemic consequences and lead to premature onset of chronic 
disease and death. Senescent cells secrete factors that can negatively alter their 
microenvironment (Coppe et al 2010), which is termed the bystander effect.  The bystander 
effects also encompasses the increased oxidative stress and concentration of 
proinflammatory cytokines (Campisi and d'Adda di Fagagna 2007, Nelson et al 2012) in 
the vicinity of senescent cells.  It has been hypothesized that DNA damage response 
proteins facilitate this process to warn surrounding cells of their potentially harmful 
condition (Rodier et al 2009). 
     
Mechanisms of Metabolic Dysfunction 
Oxidative stress  
Since oxidative stress and inflammation are central to obesity, it is important to 
understand adipocytes in terms of their contributions to and role in ROS metabolism.  ROS 
is a collective term for chemical species (e.g. superoxide anion (O2-), hydrogen peroxide 
(H2O2) and the hydroxyl radical (HO )) that are formed after incomplete reduction of 
oxygen.  ROS are potentially toxic because they contain oxygen, which makes them highly 
chemically reactive.  The imbalance of antioxidant events and production of ROS generates 
oxidative stress, which can lead to tissue damage (Bergamini et al 2004).  For example, 
oxidative stress can cause structural and conformational damage to proteins, thereby 
generating new antigens that provoke immune responses and result in inflammation (Adler 




Oxidative damage to proteins can affect the function of the entire organism (i.e. by 
damaging enzymes, receptors, transport proteins, cytoskeleton components and disrupt 
DNA repair pathway activity).  In particular, insulin exposure to ROS increases the 
concentration of free carbonyl groups, which encourages the formation of peroxidation 
products on insulin’s amino acid side chains.  The resulting changes can cause the insulin 
protein to aggregate, cross-link, and fragment, thus affecting immunoreactivity (Olivares-
Corichi et al 2005), and perhaps giving biological evidence of insulin resistance in vivo. 
ROS are required signaling molecules that are necessary in most basic biological 
processes.  However, they are harmful and causative agents in many diseases when their 
balance is disturbed.  ROS molecular recognition is at the level of amino acids, or the 
atomic level, unlike other types of specific signaling, in which a ligand binds non-
covalently to its receptor via conformational changes.  To date, there is much controversy 
regarding the specificity of ROS signaling (Adler, et al. 1999).  ROS signaling occurs 
through chemical signaling that leads to covalent protein modifications, which presumably 
would lead to indiscriminate and non-specific ROS signaling.  However, ROS redox 
mechanisms have high specificity, but it is not clear how this is achieved in vivo 
(D'Autréaux and Toledano 2007, Møller and Sweetlove 2010).   
ROS are crucial regulators in most systemic processes in the body.  In many diseased 
states, such as obesity, ROS and oxidative stress are increased (Gutowski and Kowalczyk 
2013).  The genetic, proteomic, cellular and systemic damage from oxidative stress during 
obesity could be responsible for inflammation and many of the pathologies associated with 
the obese state.  Chronic low-level inflammation is a hallmark of most diseases related to 




Hotamisligil 2005).  Obese people also have increased biomarkers of oxidative stress due 
to over nutrition and inflammation (Block et al 2002, Dandona 2002, Dandona and Aljada 
2002).  Further, obese people have more plasma ROS than people of a normal weight 
because their excessive fat may promote an oxidizing extracellular environment (Gletsu-
Miller et al 2009).   
 When adipose tissue is subject to increased oxidative stress and inflammation, it 
impairs adipocyte maturation from preadipocyte precursors (Findeisen, et al. 2011).  This 
can cause defective adipokine (cytokines released from adipocytes) and insulin signaling 
(Stentz et al 2004).  Defective signaling can cause an infiltration of inflammatory cells, 
increased cell death, and the loss of antioxidant protection (Fernandez-Sanchez, et al. 2011, 
Mlinar and Marc 2011, Parola and Marra 2011). Therefore, oxidative stress is perhaps the 
most common pathology that all of the various comorbidities of obesity have in common 
(Kral et al 2010, Lepor et al 2013, Malik, et al. 2013, Must, et al. 1999).   
Immune response 
  When a pathogen is able to infect our bodies, constantly circulating leukocytes will 
detect the infection and cross the blood barrier to the site of the infection.  This then starts 
the inflammatory process, which is a consequence of the body’s immune response.  
Inflammation is characterized by redness, heat, swelling and pain and is a normal response 
in the process of healing.  Varying degrees of the inflammatory response are present at all 
times in many disease states, particularly those that are associated with obesity, such as 




in that it is necessary for healing from various infections but also can exacerbate many 
disease states. 
The attraction of leukocytes to tissue is regulated by chemokines, a type of cytokine.  
Chemokines are secreted by damaged tissues, which cause a local inflammation response 
which directs circulating immune cells to the damaged tissue (Luster 1998). Circulating 
leukocytes enter infected tissue via extravasation. Extravasation is the process where 
leukocytes adhere to and pass between endothelial cells lining walls of blood vessels 
(Carmeliet et al 2001).  The endothelial cells express specific leukocyte cell adhesion 
molecules that direct leukocytes to the site of the infection.  Some cell adhesion molecules 
are expressed constitutively while others are only expressed after cytokine stimulation.  
Therefore, the expression of cell adhesion molecules on both endothelial cells and 
leukocytes is important for the induction of the inflammation response.   
The biological activity of cytokines in promoting inflammation in response to an 
infection is necessary to promote healing.  We believe this same process may exacerbate 
and induce many of the comorbidities of obesity.  Below, is an explanation of how 
cytokines affect disease resistance, in terms of B and T cell activation, and insights on how 
this helpful process may be harmful in perpetuating the comorbidities of obesity.   
B cells and T cells both recognize antigens, but B cells can directly recognize antigens 
via their membrane immunoglobins, while T cell antigen recognition requires the 
interaction of its T cell receptor with the antigen/ major histocompatibility complex 
(MHC).  In addition, MHC’s are only found on antigen presenting cells, while B cells can 
interact with any cell that express the correct surface markers.  Once B and T cells are 




secretion of cytokines.  For example, activated T-helper cells can secrete interleukins 2, 4 
or 5 that can cause B cell proliferation and induce class switching of B cells to IgE.  On the 
other hand, activated T-helper cells can also secrete interferon gamma, which blocks the 
action of interleukin 4 in the class switching of B cells to IgE.   
Cytokines are low-molecular-weight proteins or glycoproteins that play an important 
role in cell-to-cell communication.  Cytokines have a short half-life in plasma or the blood 
stream and are principally produced by T-helper cells, dendritic cells and macrophages.  
Cytokines can regulate the development of immune effector cells and some cytokines 
possess the ability to have direct immune effector functions themselves.  The susceptibility 
of cells to cytokines is dependent on specific membrane receptors.  Most cytokines have 
very high affinity for their receptors, so biological effects can result from picomolar 
concentrations of cytokines (Nathan and Sporn 1991).   
Once cytokines are released, they can activate and start signal transduction pathways 
that can affect a large network of interacting cells (Starr et al 1997).  Cytokines are required 
for many responses, such as the development of the cellular and humoral response, 
induction of the inflammatory response, regulation of hematopoiesis, control of 
proliferation and differentiation and wound healing.  The functions of cytokines are exerted 
in an antigen-nonspecific manner.  Whichever cells have appropriate surface receptors are 
susceptible to cytokine signaling.  Thus, the specificity of cytokines is primarily controlled 
by expression of cytokine receptors on individual cells.   
The term cytokine usually refers to proteins secreted from immune cells.  However, 
preadipocytes, can function similarly to immune cells and secrete cytokines (Wang et al 




al 2005, Trayhurn and Wood 2004, Trayhurn and Wood 2005), although there is 
inconsistency among the literature regarding nomenclature and the term cytokine is 
commonly used. Unfortunately, a hallmark of many diseases is chronic inflammation, 
which is usually the accumulation and activation of macrophages.  This accumulation can 
stimulate fibroblast production, resulting in fibrosis and scar tissue that interferes with 
normal tissue function.  An applicable example of how this happens during metabolic 
dysfunction would be the fibrotic conditions that affect adipose tissue and the kidney, liver 
and heart during metabolic dysfunction (K Sun et al 2013). There is even a life-threatening 
disease related to chronic macrophage activation called macrophage-activation syndrome.  
The disease is commonly observed in children with chronic immune dysfunction (such as 
those with juvenile idiopathic arthritis or systemic lupus erythematosus).  This disease is 
often under- or mis- diagnosed and the only available therapies are immune suppressing 
drugs, which are known to be a difficult long-term treatment option.  
Linking Metabolic Derangements to Adipocytes  
Inflammation  
The obese state is usually synonymous with increased oxidative stress(Furukawa, et 
al. 2004, Karbownik-Lewinska et al 2012), chronic inflammation (Cildir et al 2013) and a 
distorted immune response (Cancello and Clement 2006, Donath, et al. 2013).  Adipose 
tissue of obese people has more macrophages than adipose tissue from normal individuals.  
This fact was some of the earliest evidence that demonstrated a mechanistic link between 
increased inflammation and the obese state (Kress, et al. 2005).  An expression analysis of 




markers, such as CD68 was performed, and revealed that obese people have more 
macrophages in their adipose tissue.  In addition, macrophages of obese individuals 
participate directly in adipose tissue inflammation by increasing the expression of IL-6, 
TNF-α and inducible nitric oxide synthase (iNOS) (Bourlier et al 2012). 
TNF-α and IL-6 are proinflammatory cytokines of innate immunity and serve many 
necessary purposes such as regulating cell death, promoting vasculature, activating 
neutrophils and help influencing adaptive immunity by promoting proliferation and 
antibody secretion (Seidell 2000).  In terms of insulin resistance and type 2 diabetes, the 
secretion and plasma concentrations of IL-6 and TNF-α are higher than in healthy 
individuals and their dysregulation causes problems during many diseased states (Abraham 
et al 2007).  For instance, TNF-α can effect changes that directly impact insulin resistance, 
such as inhibiting phosphorylation of the insulin receptor and preventing its translocation 
from the cytoplasm to the membrane and thus promoting hyperglycemia (Popkin and Doak 
1998).  In addition, IL-6 inhibits insulin receptor signal transduction and insulin action in 
hepatocytes (Must, et al. 1999).  Taken together, the increased concentrations of IL-6 and 
TNF-α in type 2 diabetics might be explained by dysfunctional preadipocytes acting as 
immune cells.  In acting as immune cells, preadipocytes may secrete high levels of 
cytokines and causing a feed-forward loop and promoting the disease state typical of 





Figure 3: Cytokines 
The toxic effects of cytokines may damage preadipocytes beyond repair, causing them to lose their ability to differentiate, even if normal 
extracellular homeostasis exists.  If ability to differentiate is lost, and differentiation is blocked, overall metabolism is negatively affected 





Children, and other mammals during early development, have the unique ability to 
increase adipocyte number. Adults typically do not make adipocytes unless they to replace 
ones that have malfunctioned or died (Chumlea et al 1981, Kirkland et al 1990, Strawford 
et al 2004).  Therefore, individuals that were obese as children may be more efficient in 
storing more fat, either from their diet or from metabolic processes.  This is because they 
have more adipocytes, and thus storage capacity, in adulthood than their peers who were 
not obese during childhood (Bonnet et al 1970, Spalding, et al. 2008).  In adults, there is 
decreased ability for the body to increase total adipocyte number, and this usually only 
happens under extreme obesity conditions (Kovsan et al 2011, McDonald and Horwitz 
1999).  Unfortunately, this inability to make new adipocytes can inflict severe stress on 
existing adipocytes, causing them to expand to an unnaturally large size, becoming 
unresponsive, and eventually becoming insulin resistant (West 2009).  
The insulin sensitivity of obese individuals varies (Arner, et al. 2011).  The location 
of the excess the adipose tissue is thought to play a key role in determining the insulin 
sensitivity.  An obese individual with a gynoid body shape may retain their insulin 
sensitivity more than an obese individual with an android body shape with the same body 
fat percentage (Dolinkova et al 2008, Epel et al 2000, Kaplan 1989).  However, more recent 
studies debate the validity of this presumption.  It has been shown that an increase in body 
fat, not dependent on fat depot distribution, is the strongest correlation for an increase in 
the risk of developing obesity related diseases (Gregg et al 2005), not body shape or 




There is research that shows the subcutaneous adipose tissue of insulin resistant 
individuals is composed of smaller adipocytes than adipose tissue from insulin sensitive 
individuals.  Interestingly, these small adipocytes from the insulin resistant individuals had 
lower lipid storage capacity, which is a hallmark of adipose tissue dysfunction, compared 
to the adipocytes of insulin sensitive individuals (McLaughlin et al 2010).  Yet, drugs used 
to treat insulin resistance in type 2 diabetics, such as a thiazolidinediones (TZDs) (Day 
1999), which are PPARγ agonists (Spiegelman 1998), spur the maturation of new 
adipocytes, creating increased lipid storage capacity that can help alleviate hyperglycemia 
and promote insulin sensitivity.  TZDs increase the number of small adipocytes and 
promote insulin sensitivity in these cells, therefore not all small adipocytes are unable to 
take up lipids properly (Spiegelman 1998).   
Some data support that the insulin responsiveness of large and small adipocytes from 
the same depot does not vary (Wueest, et al. 2009), suggesting that adipocyte size is not 
related to insulin resistance.  Conversely, there are other data that show larger, or 
hypertrophic adipocytes, are the predominate type of adipocytes found in individuals with 
insulin resistance (Yang, et al. 2012). Also adipocyte hypertrophy is associated with 
proinflammatory factors and cellular necrosis (Jo, et al. 2009), both which are known 
factors that help drive insulin resistance. Furthermore, obese insulin resistant individuals 
have larger adipocytes and more macrophages in their subcutaneous fat than do obese 
insulin sensitive individuals (Molgat, et al. 2011).  The molecular mechanisms that 
perpetuate this phenotype are largely misunderstood, but understanding this insulin 
resistant state will provide clinicians with valuable treatment options in dealing and 




CHAPTER 2:  THE KINASE ACTIVITY OF ATM AND DNA-
PKCS IS CRITICAL DURING ADIPOGENESIS  
Abstract 
Adipogenesis, the process of adipocyte differentiation, and lipid droplet formation are 
key processes regulating adipocyte integrity and preventing dysfunction.  It has been shown 
that both processes are regulated by oxidative stress.  The DNA damage repair proteins 
ATM and DNA-PKcs can be activated in response to oxidative stress in normal human 
fibroblasts.  Therefore, we hypothesize ATM and DNA-PKcs play a critical role in 
maintaining adipocyte integrity.  In this study, the standard adipocyte differentiation 
process of murine 3T3-L1 preadipocytes and mouse embryonic fibroblasts were 
manipulated.  We used chemical inhibitors of ATM and DNA-PKcs, antioxidants, and 
prooxidants.  After treatments, we studied the cellular morphology, lipid accumulation, 
oxidative damage, and the expression of lipid droplet associated proteins.  We found that 
ATM and DNA-PK are necessary for lipid accumulation and they exert their effects via a 
ROS dependent pathway.  Based on our results, ATM and DNA-PK could emerge as 
molecular targets for intervention of obesity and related comorbidities.   
Introduction 
Rationale 
Although the initial studies of ATM and DNA-PK focused on their role in DNA 




response.  ATM is activated by oxidative stress (Guo, et al. 2010a, Guo, et al. 2010b) and 
we have shown that DNA-PK is necessary to relay the selenium-induced ROS response in 
human fibroblasts (Rocourt et al 2013).   ATM and DNA-PKcs are involved in cellular 
senescence (Rocourt, et al. 2013, Wu, et al. 2010) and the secreted components of senescent 
cells are thought to disrupt tissue function and structure (Campisi and d'Adda di Fagagna 
2007).  As the complications of obesity can in part be explained by the structure and 
function of adipocytes, our central hypothesis is that ATM and DNA-PKcs are critical for 
maintaining preadipocyte and adipocyte integrity.   
Significance  
Although attempts have been made to understand obesity related diseases at the 
molecular level, obesity, and the related complications, are predicted to continue to 
increase (Malik, et al. 2013).  The mechanism by which being overweight or obese 
predispose individuals to comorbidities is not clear (Allison et al 1999, Guh et al 2009, 
Paeratakul et al 2002).  To further complicate matters, current screening methods for 
identifying those at risk for obesity associated comorbidities and metabolic dysfunctions 
are primarily anthropometric measurements such as BMI and waist circumference (Abate 
2012). These fail to capture a percentage of individuals that are risk for developing 
metabolic diseases because they do not meet the criteria or cut offs (Waugh et al 2013).   
Not only is there a need for better screening for obesity-related comorbidities, but 
there is also a need to better understand the obesity-mortality paradox, in which ~ 10% 
people who are overweight or mildly obese are metabolically healthy while ~ 8-24% of 




2013).  We and others (Guilherme, et al. 2008, Trayhurn 2013, Vigouroux, et al. 2011) 
believe that unifying factors among individuals with metabolic dysfunctions are 
disturbances in adipose tissue functioning.   
Hypothesis 
We believe that oxidative stress is central to the comorbidities of obesity.  It is our 
hypothesis that the DNA damage response proteins, ATM and DNA-PKcs, serve a critical 
role in regulating ROS throughout the lifecycle of adipose tissue.  It is our view that 
dysfunctional adipocytes are responsible for the comorbidities of obesity; with the central 
driving force being ROS and oxidative damage triggering a senescence-associated 
secretory phenotype (Kirkland et al 2002, Rodier, et al. 2009, Tchkonia, et al. 2010) in 
preadipocytes, thus creating toxic adipose tissue that causes systemic effects.   
To test our hypothesis, we used murine 3T3-L1 fibroblasts and murine embryonic 
fibroblasts and employed the use of specific kinase inhibitors to determine the requirement 
of ATM and DNA-PK during adipogenesis.  After critical analysis of the data, we 
performed experiments that attempted to explain the molecular underpinnings of how ATM 
and DNA-PK contribute to adipocyte homeostasis. 
Methods 
Cell lines and maintenance  
SV40-transformed wild-type, DNA-PKcs-/-, Ku70-/- and Ku80-/- Mouse Embryonic 
Fibroblasts (MEFs) from E13.5 embryos were obtained from UT Southwestern Medical 




2011).  Murine 3T3-L1 preadipocytes (CL173) were purchased from American Type 
Culture Collection (Manassas, VA) (See Figure 2: Lipid accumulation in 3T3-L1 
adipocytes).  Preadipocytes were cultured in Dulbecco’s minimum essential medium 
(DMEM) (GibcoBRL, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS) 
(GibcoBRL) and 1% penicillin/streptomycin (GibcoBRL) and were maintained in a 37° C 
humidified atmosphere in either 20% oxygen or 3% oxygen.   
Adipocyte differentiation 
Adipogenesis was induced by using induction media; 10% FBS DMEM was 
supplemented with the hormonal proadipogenic cocktail of 166 nM insulin dissolved in 
0.02 M HCl, 0.5 mM 3-isobutyl-1-methyl-xanthine (IBMX) dissolved in 0.5N potassium 
hydroxide (KOH) and 1 µM dexamethasone (Dex) dissolved in ethanol (Hemati et al 1997) 
to cells that were two days past 100% confluency (designated Day 0).  After two days, the 
induction media was refreshed for 1 day and then the cells were maintained in insulin media 
(166 nM insulin in 10% FBS DMEM) until used for experiments, typically on day 12~15 
(See Figure 1: Timeline of Adipocyte Differentiation). 
Lipid accumulation 
To detect lipid droplets, the coverslips were incubated with HCS LipidTOX™ Green 
neutral lipid stain (1:100 in BSA, Invitrogen Molecular Probes, Carlsbad, CA) for 1 h at 
room temperature.  Then the coverslips were washed with 1x PBS and mounted onto slides 
with a drop of Prolong® Gold mounting media containing 4,6-diamidino-2-phenylindole 
(DAPI) (Invitrogen Molecular Probes), which serves to adhere the coverslip to the slide, 






Cells were treated with, without, or in combination with the following: the ATM 
kinase inhibitor KU 55933 (10 µM in DMSO, Tocris, Ellisville, MO), the DNA-PK kinase 
inhibitor NU 7026 (10 µM in DMSO, Tocris), the antioxidants N- acetylcysteine (NAC) 
(10 mM in phosphate buffered saline (PBS), Sigma- Aldrich) and 2, 2, 6, 6-tetramethyl-
piperidine-1-oxyl (TEMPO) (1 mM in PBS, Sigma- Aldrich), the prooxidant hydrogen 
peroxide (H2O2) (10 µM in double distilled water, Fischer Scientific, Waltham, MA) and 
Dimethyl sulfoxide (DMSO) (Vehicle, Sigma- Aldrich,).  All chemicals were added to the 
cell culture and incubated at 37° C for the times specified by the experiment.  Please refer 
to  
Appendix for more detailed information.  
Co-culture 
For co-culture experiments, undifferentiated 3T3-L1 fibroblasts were grown on 
porous wells that nestle into standard 6-well plates.  The fibroblasts were treated with ATM 
and DNA-PK inhibitors to induce senescence.  Upon senescence, the wells with the treated 
cells were added to individual wells of a 6-well dish that contained 3T3-L1 cells, grown on 
coverslips that had been hormonally induced to undergo adipogenesis.  Thus, by co-
culturing, the differentiated 3T3-L1 cells were exposed to the cellular environment and 
culture medium of the senescent preadipocytes.  The differentiated cells were then 





Oil-Red-O  (ORO) (Sigma-Aldrich) staining was conducted, as previously described 
(Ramirez-Zacarias et al 1992, Ross et al 1999, Ross et al 2000, van Goor et al 1986) with 
little modification, in order to determine lipid accumulation _ENREF_7 Dye preparation: 
0.5 g of ORO was dissolved in 250 mL isopropanol to form a stock solution.  30 minutes 
before staining, 20 mL of deionized water was added to 30 mL of the stock solution to 
make the working solution, and then put on a stir plate at 50° C until adipocyte staining 
was completed.   
Cell staining:  Adherent cells were gently rinsed with phosphate-buffered saline (PBS) 
then fixed in a 4% paraformaldehyde solution for 1 h, washed with 1x PBS then refixed 
with 4% paraformaldehyde solution for 2-3 days.  After fixation, the cells were rinsed with 
1x PBS followed by 60% isopropyl alcohol, which was added and allowed to evaporate.  
The cells were then stained with the ORO working solution for 10 min.  Plates were rinsed 
3x with tap water and allowed to dry.  Photographs were taken, and cells were subsequently 
analyzed as described below.   
Quantification of stained cells: Stained cells were counted under a light microscope 
(40x- 400x magnification) and given a score based on the percent lipid accumulation when 
compared to the differentiated control, which we designated to be 100%.   
Senescence 
To determine senescence, we detected the expression of senescence associated-β-




MA) according to the manufacturer's instructions and our previous publication (Rocourt, 
et al. 2013).  
Coverslip preparation  
Immunofluorescence analysis was performed as described previously with slight 
modifications (Nioi et al 2007, Rocourt, et al. 2013)_ENREF_9.  MEFs and 3T3-L1 cells 
were seeded on coverslips in 6-well plates at 70% confluency then differentiated and 
treated as described above.  At the end of the experiment, coverslips were rinsed in PBS, 
fixed in 4 % paraformaldehyde solution in PBS for 30 min at room temperature and then 
washed twice with 1x PBS.  
Antibody detection   
Cells were prepared as described above with minor modifications as follows; after 15 
min fixation with a paraformaldehyde solution, the cells were permeabilized with ice-cold 
methanol for 10 min at -20° C.  Next, the cells were permeabilized again for 10 min in 
0.3% Triton X-100 and then blocked in 10% normal goat serum / 0.3 M glycine in 1x PBS 
for 1 h to block non-specific protein-protein interactions.  Individual coverslips were 
hybridized with either of the following antibodies for 1 hour (h) at room temperature (RT): 
monoclonal anti-γH2A.X at Serine 139 (γH2A.X) (1: 250 in BSA, Abcam, Boston, MA) 
and perilipin D418 (1:200 in BSA, Cell Signaling, Danvers, MA).   
After incubation with antibodies, the coverslips were washed in 1x PBS, and 
incubated with the appropriate secondary antibodies (Alexa Fluor 488-conjugated goat 
anti-rabbit for perilipin and Alexa Fluor 594-conjugated goat anti-mouse γH2A.X both 




were then washed 3x in 1x PBS and the coverslips were mounted onto slides that contained 
a drop of DAPI and were visualized using immunofluorescent microscopy. 
Quantification of antibody data 
The immunostaining was visualized using the 63x oil-immersion lens on a Zeiss Axio 
Observer Z1m (Zeiss, Thornwood, NY).  A z-stack of 10 photos was taken of the 
appropriate channels (DAPI, GFP and DsRed).  Images were obtained using the same 
parameters of brightness, contrast and exposure time (DAPI 5 ms, LipidTOX 125 ms, 
γH2A.X 40 ms, and perilipin 75 ms).  Images were then processed using the deconvolution 
function of the software AxioVision Release 4.7.2.0.  Lipid droplet data were quantified 
by comparing the saturation, size and distribution of lipid droplets (LipidTOX) as well as 
counting foci as described previously (Rocourt, et al. 2013) for  perilipin and γH2A.X data. 
Granularity 
Flow cytometry was conducted to determine the degree of lipid accumulation as 
previously described (Lee et al 2004).  In preparation for flow cytometry, the samples were 
trypsinized for 3 min, then serum-containing media was added to stop digestion and the 
suspension was centrifuged (1000 rpm, 2 min at RT) to form a pellet.  The supernatant was 
discarded, the cells resuspended in ice-cold 1x PBS and were immediately analyzed using 
a BD FACSCanto II flow cytometer.  Increasing side scatter (SSC) and forward scatter 
(FSC) were used to indicate lipid accumulation and cell size, respectively.  The data was 





All the experiments were independently performed and repeated three times.  We 
defined the control as differentiated 3T3-L1 or MEF cells, induced to undergo adipogenesis 
as described above unless stated otherwise in the text.  The data were analyzed using 
GraphPad Prism software version 5.04 (GraphPad Software Inc., La Jolla, CA).  Two 
tailed, one- sample t-tests were applied to determine statistical significance (*, p<0.05) 
between treatments.   
Results 
ATM and DNA-PK kinase activity are necessary for lipid accumulation 
Lipid accumulation in 3T3-L1 cells was significantly decreased after treatment with 
the ATM and DNA-PK competitive protein kinase inhibitors, NU 7026 and KU 55933 
(See Figure 4: ATM and DNA-PK kinase activity are necessary for lipid accumulation).  
The maximal effect of kinase inhibition on lipid droplet formation occurred when 
inhibition was induced prior to hormonal induction of adipogenesis (See Figure 5: ATM 
and DNA-PK kinase inhibition has maximal effect on lipid accumulation when added 







Figure 4: ATM and DNA-PK kinase activity are necessary for lipid accumulation  
3T3-L1 fibroblasts were differentiated and treated with the ATM inhibitor, KU 55933, (10 µM in DMSO; 48 h treatment started day 0 of adipogenesis) or the DNA-PK inhibitor, 
NU 7026, (10 µM in DMSO; 48 h treatment started day 0 of adipogenesis) and cultured in 20% oxygen (A & B) or 3% oxygen (C & D).  Lipid accumulation was determined by 
Oil-Red-O staining (A & C), analyzed using a light microscope (400x), or LipidTOX (1:200 in BSA, 1 h RT) staining (B & D), analyzed using an immunofluorescent microscope 
(63x oil-immersion).  Each treatment was given a score based on the percent Oil-Red-O or LipidTOX saturation when compared to the differentiated control, which we designated 
to be 100%.  Values are means ± S.E.M. (n= 3; * denotes significance (p<0.05) as compared to differentiated 3T3-L1 cells).  (E-G)  Representative oil-immersion photographs  
(DAPI, blue color, nuclear stain; GFP, green color, lipid droplet stain) of differentiated 3T3-L1 fibroblasts (E) treated with 10 µM KU 55933 (F) or 10 µM NU 7026 (G) and cultured 










Figure 5: ATM and DNA-PK kinase inhibition has maximal effect on lipid accumulation when added before inducing 
adipogenesis 
3T3-L1 cells were hormonally induced to undergo differentiation (166 nM Insulin, 0.5 mM IBMX, and 1 µM dexamethasone in 10% FBS DMEM) treated with the ATM kinase 
inhibitor KU 55933 (10 µM dissolved in DMSO) or the DNA-PK kinase inhibitor NU 7026 (10 µM dissolved in DMSO) at the indicated time points then hybridized with LipidTOX 
(1:200 in BSA, 1 h RT) to visualize lipid droplets.  Cells were observed with a fluorescence microscope to observe lipid staining (GFP, green color) and nuclear staining (DAPI, 




ATM and DNA-PKcs are critical for lipid accumulation in mouse embryonic fibroblasts 
Because of the reliability and accuracy of using chemical inhibition to study kinase 
activity, we employed mouse embryonic fibroblasts (MEFs) that have Atm and PRKDC 
(which encodes the DNA-PKcs) knocked out.  We chose these cells lines to study the role 
of the ATM and DNA-PKcs proteins in adipogenesis, without the use of ATP competitive 
protein kinase inhibitors, which could potentially have off target effects.  MEFs without 
the ATM protein accumulated significantly less lipids than did the wild type counterpart 
(See Figure 6: Knockout of the ATM gene decreases lipid accumulation in MEFs).  
 MEFs with DNA-PKcs knocked out revealed minuscule lipid accumulation following 
hormonal induction of adipogenesis (See Figure 7: DNA-PKcs-/- MEFs show little lipid 
accumulation despite hormonal induction of adipogenesis).  MEFs without DNA-PKcs had 
a distinct fibroblast-like phenotype.  Furthermore, differentiated DNA-PKcs-/- MEFs were 
much larger in size and had much smaller lipid droplets than the wild type control (See 








Figure 6: Knockout of the ATM gene decreases lipid accumulation in MEFs 
Normal mouse embryonic fibroblasts (MEFs), and those without the ATM gene, were subject to hormonal stimulation to undergo adipogenesis (166 nM Insulin, 0.5 mM IBMX and 
1 µM dexamethasone in 10% FBS DMEM).  Lipid accumulation was determined by analyzing Oil-Red-O staining using a light microscope (400x).  Each treatment was given a 
score based on the percent Oil-Red-O saturation when compared to differentiated wild type MEFs, which we designated to be 100%.  Values are means ± S.E.M. (n= 3; * denotes 
























Figure 7: DNA-PKcs-/- MEFs show little lipid accumulation despite hormonal induction of adipogenesis 
Wild type and DNA-PKcs-/- mouse embryonic fibroblasts (MEFs) were subject to hormonal stimulation to undergo adipogenesis (166 nM Insulin, 0.5 mM IBMX, and 1 µM 
dexamethasone in 10% FBS DMEM) and cultured in 20% oxygen (A) and 3% oxygen (B).  Lipid accumulation was determined by LipidTOX staining (1:200 in BSA, 1 h RT) 
visualized using an immunofluorescent microscope (63x oil-immersion).  Scores were based on the percent LipidTOX saturation of differentiated wild type MEFs, which we 
designated as 100%.  Values are means ± S.E.M. (n= 3; * denotes significance (p<0.05) as compared to differentiated wild type MEFs).  Representative oil- immersion photographs 







Figure 8: DNA-PKcs-/- MEFs are larger and have smaller lipid droplets than wild type MEFs 
Differentiated (A) wild type and (B) DNA-PKcs-/- mouse embryonic fibroblasts (MEFs) cells hormonally induced to undergo adipogenesis (166 nM Insulin, 0.5 mM IBMX, and 1 
µM dexamethasone in 10% FBS DMEM).  Upon differentiation, cells were analyzed by observing the side scatter (y-axis) to forward scatter (x-axis) ratio, with higher values 





DNA-PK acts independently of the NHEJ pathway during adipogenesis 
We also employed MEFs that were homozygous negative for Ku80 and Ku70, 
necessary proteins for the non-homologous end-joining pathway (NHEJ).  The Ku80 and 
Ku70 proteins make up a heterodimer that together with DNA-PKcs, make up the 
holoenzyme DNA-PK (Lees-Miller, et al. 1990).  This heterodimer is the key kinase in the 
NHEJ pathway that repairs DNA DSBs (Lees-Miller and Meek 2003). In our experiment, 
the silencing of Ku70 and Ku80 did not significantly affect lipid accumulation in 
differentiated MEFs.  This finding suggests that DNA-PKcs affects lipid droplet formation 
independent of its role and function in the NHEJ pathway (See Figure 9: DNA-PK’s role 
in adipocyte differentiation is independent from its function in the non-homologous end-


























Figure 9: DNA-PK’s role in adipocyte differentiation is independent from its function in the non-homologous end-
joining pathway 
Wild type mouse embryonic fibroblasts (MEFs) and MEFs with the following mutations; Ku70-/-, Ku80-/- and DNA-PKcs-/- , and DNA-PKcs3A/3A (alanine mutation at the catalytically 
active site which results in significantly decreased kinase activity) were subjected to hormonal stimulation to undergo adipogenesis (166 nM Insulin, 0.5 mM IBMX, and 1 µM 
dexamethasone in 10% FBS DMEM).  Lipid accumulation was determined by analyzing Oil-Red-O staining using a light microscope (400x).  Each treatment was given a score 
based on the percent Oil-Red-O saturation when compared to differentiated wild type MEFs, which we designated to be 100%.  Values are means ± S.E.M. (n= 3; * denotes 




ATM and DNA-PK inhibition decrease perilipin concentration 
Because we saw decreased lipid droplet formation when we treated 3T3-L1 with ATM 
and DNA-PK kinase inhibitors, we wanted to investigate which factors were responsible.  
Therefore, we chose to investigate the expression of the lipid droplet protein, perilipin 1.  
Perilipins coat lipid droplets and serves as a scaffolding protein.  Furthermore, 
chromosomal variations at the perilipin locus are associated with obesity risk (Tai and 
Ordovas 2007) and some perilipin family members direct lipase to the lipid droplet in order 
to facilitate lipolysis (Wang, et al. 2011, Wang et al 2003).  For these reasons, we 
hypothesize that ATM and DNA-PK inhibition could be decreasing perilipin localization 
to lipid droplets, which might explain why we observed decreased lipid accumulation. 
In ATM and DNA-PK chemically inhibited 3T3-L1 adipocytes, perilipin 
concentrations were significantly decreased when compared to normally differentiated 
cells (See Figure 10: ATM and DNA-PK inhibition decreases perilipin concentration).  
Interestingly, we observed that the vehicle used to dissolve the chemical inhibitors, DMSO, 
which is known to have anti-inflammatory or antioxidant properties, slightly increased 







Figure 10: ATM and DNA-PK inhibition decreases perilipin concentration  
3T3-L1 fibroblasts were differentiated and treated with the ATM inhibitor, KU 55933, (10 µM in DMSO; 48 h treatment started day 0 
of adipogenesis) or the DNA-PK inhibitor, NU 7026, (10 µM in DMSO; 48 h treatment started day 0 of adipogenesis) and cultured in 
20% oxygen.  Differentiated cells were probed for perilipin (1: 200 in BSA, 1 h RT; 2° Ab Alexa Fluor 488-conjugated goat anti-rabbit 
1: 200 in BSA, 1 h RT) and LipidTOX (1: 100 in BSA, 1 h RT) then visualized using an immunofluorescent microscope (63x oil-
immersion).  Each treatment was given a score based on the total perilipin concentration when compared to the differentiated control, 
which we designated to be 100%.  Values are means ± S.E.M. (n= 3; * denotes significance (p<0.05) as compared to differentiated 3T3-
L1 cells).  Photographs are representative of data in bar graph and the vehicle, DMSO, used to dissolve the inhibitors.  DAPI, blue color, 
nuclear stain; GFP, green color, lipid droplet stain; DsRed, red color, perilipin antibody; Merge, yellow color, co-localization of perilipin 




ROS promotes lipid accumulation in 3T3-L1 and MEF models of adipogenesis 
Because we have previously shown that ATM and DNA-PK are activated in response 
to oxidative stress in human normal fibroblasts (Wu, et al. 2010), we hypothesized that the 
decreased adipogenesis after KU 55933 and NU 7026 treatment was due to changes in 
oxidative stress levels.  Furthermore, literature has indicated that oxidative stress is 
required for differentiation (Higuchi et al 2013) but that chronic increased oxidative stress 
can inhibit adipogenesis (Findeisen, et al. 2011) and promotes adipogenesis.  Whatever the 
mechanism, it is likely that oxidative stress is a critical regulator of adipogenesis. 
In order to test our hypothesis that ATM and DNA-PK act via a ROS dependent 
pathway during adipogenesis, we first established the effect of oxidative stress in our 
models.  Briefly, we treated differentiating 3T3-L1 with the antioxidants NAC and TEMPO 
as well as the ROS generating prooxidant H2O2 and cultured them in 3% and 20% oxygen 
and measured the lipid accumulation (See Figure 11: The effect of oxidative stress on lipid 
accumulation in 3T3-L1 cells).  Our results suggest that increased ROS levels results in 
increased lipid droplet accumulation and that antioxidant treatment slightly diminishes 
lipid droplet formation.  
We also performed similar experiments in our wild type MEFs to establish the effect 
that oxidative stress played in their ability to accumulate lipids (See Figure 12: The effect 
of oxidative stress on lipid accumulation in MEFs).  We found that differentiated wild type 
MEFs, when pretreated with H2O2 and NAC, had similar lipid accumulation patterns to the 
3T3-L1-cell line.  H2O2 promoted increased lipid droplet formation while NAC slightly 















Figure 11: The effect of oxidative stress on lipid accumulation in 3T3-L1 cells 
3T3-L1 fibroblasts differentiated and treated with the prooxidant H2O2 (10 µM in dd H2O, 48 h treatment started day 0 of adipogenesis) or the antioxidants NAC (10 mM in PBS, 48 
h treatment started day 0 of adipogenesis) and TEMPO (1 mM in PBS, 48 h treatment started day 0 of adipogenesis) and cultured in 20% oxygen (A & B) or 3% oxygen (C & D).  
Lipid accumulation was determined by analyzing Oil-Red-O staining (A & C) using a light microscope (400x) or by LipidTOX staining (B & D) using an oil-immersion 
immunofluorescent microscope (63x).  Each treatment was given a score based on the percent Oil-Red-O or LipidTOX saturation when compared to the untreated control, which we 
designated to be 100%.  Values are means ± S.E.M. (n= 3; * denotes significance (p<0.05) as compared to differentiated 3T3-L1 cells).  (E) Light microscope photograph of 
differentiated 3T3-L1 adipocytes illustrating the proadipogenic additive effect of H2O2 treatment (10 µM in dd H2O, 48 h treatment started day 0 of adipogenesis) and culturing cells 






Figure 12: The effect of oxidative stress on lipid accumulation in MEFs 
Wild type mouse embryonic fibroblasts were subject to hormonal stimulation to undergo adipogenesis (166 nM Insulin, 0.5 mM IBMX, and 1 µM dexamethasone in 10% FBS 
DMEM) and treated with the prooxidant H2O2 (10 µM in dd H2O, 48 h treatment started day 0 of adipogenesis) or the antioxidant NAC (10 mM in PBS, 48 h treatment started day 
0 of adipogenesis) and cultured in 20% oxygen (A & B) or 3% oxygen (C & D).  Lipid accumulation was determined by analyzing Oil-Red-O staining (A & C) using a light 
microscope (400x) or by LipidTOX staining (B & D) using an oil-immersion immunofluorescent microscope (63x).  Each treatment was given a score based on the percent Oil-Red-





ATM and DNA-PK orchestrate adipogenesis and lipid accumulation by regulating 
oxidative tone 
In order link oxidative stress, lipid droplet accumulation and the role of ATM and 
DNA-PK kinases, we pretreated with H2O2 or NAC followed by KU 55933 and NU 7026 
treatment during adipogenesis.  Both antioxidant and prooxidant pretreatment significantly 
altered the capacity of the fibroblasts to differentiate and accumulate lipids (See Figure 13: 
ATM and DNA-PK influence lipid droplet formation via a ROS dependent pathway).  
Although antioxidant pretreatment had the largest effect, both treatments increased the 
lipid droplet formation and restored adipocyte morphology, despite the ATM or DNA-PK 
chemical inhibition.  
This effect was greatest in cells that had ATM chemically inhibited, suggesting that 
ATM is a more critical regulator, or is upstream of DNA-PK, in the regulation of ROS 
before and during adipogenesis.  Taken together, ATM and DNA-PKcs respond to ROS and 
oxidative stress and preserve a normal pattern of lipid retention in 3T3-L1 adipocytes.   
Pretreating DNA-PKcs-/- MEFs with NAC and H2O2 revealed a similar, but less 
significant, trend to the 3T3-L1 fibroblasts.  Specifically, both antioxidant and prooxidant 
treatment increased the lipid accumulation in DNA-PKcs-/- MEFs (See Figure 14: Both 
antioxidant and prooxidant treatment causes DNA-PKcs-/- MEFs to increase lipid 






Figure 13: ATM and DNA-PK influence lipid droplet formation via a ROS dependent pathway 
3T3-L1 fibroblasts were pretreated with the prooxidant H2O2 (10 µM in dd H2O, 48 h treatment started day -2 of adipogenesis) or the antioxidant NAC (10 mM in PBS, 48 h treatment 
started day -2 of adipogenesis) followed immediately by hormonal stimulation to undergo adipogenesis (166 nM Insulin, 0.5 mM IBMX, and 1 µM dexamethasone in 10% FBS 
DMEM) and (A) treatment with the ATM inhibitor, KU 55933, (10 µM in DMSO, 48 h treatment started day 0 of adipogenesis) or (B) the DNA-PK inhibitor, NU 7026, (10 µM in 
DMSO, started day 0 of adipogenesis) and cultured in 20% oxygen.  Lipid accumulation was determined by LipidTOX staining using an oil-immersion immunofluorescent 
microscope (63x).  Each treatment was given a score based on the percent Oil-Red-O or LipidTOX saturation when compared to the untreated control, which we designated to be 
100%.  Values are means ± S.E.M. (n= 3; * denotes significance (p<0.05) as compared to inhibitor only treated 3T3-L1 cells).  (C) The top row of pictures are representative 







Figure 14: Both antioxidant and prooxidant treatment causes DNA-PKcs-/- MEFs to increase lipid accumulation 
DNA-PKcs-/- MEFs were treated with the prooxidant H2O2 (10 µM in dd H2O, 48 h treatment started day -2 of adipogenesis) or the antioxidant NAC (10 mM in PBS, 48 h treatment 
started day -2 of adipogenesis) followed by hormonal stimulation to undergo adipogenesis (166 nM Insulin, 0.5 mM IBMX, and 1 µM dexamethasone in 10% FBS DMEM) and 
then cultured in 20% oxygen.  Lipid accumulation was determined by LipidTOX staining using an oil-immersion immunofluorescent microscope (63x).  Each treatment was given 
a score based on the percent LipidTOX saturation when compared to the untreated control, which we designated to be 100%.  Values are means ± S.E.M. (n= 3; * denotes significance 
(p<0.05) as compared to differentiated DNA-PKcs-/- MEFs).  The photographs represent the treatments seen in the bar graph; where the blue color is DAPI, a nuclear stain and the 




Requirement of DNA damage in differentiation 
There are various cellular rearrangements required for adipogenesis such as mitotic 
clonal expansion (Lee et al 2009), permanent growth arrest (Ailhaud et al 1990), 
rearrangement of nuclear architecture (Xiong et al 2013), cytoskeleton changes (Liu et al 
2005, Selvarajan et al 2001), up-regulation of genes (Cristancho and Lazar 2011), etc.).  It 
is our hypothesis that ATM and DNA-PK kinases could affect some of the processes 
regulating cellular rearrangement during adipogenesis via an oxidative stress related 
pathway. 
Since it was found that ATM and DNA-PK could influence adipogenesis via a ROS 
dependent pathway, we were interested in determining which pathways these kinases 
regulate. We set out to test if γH2A.X is a mediator or intermediate in the ATM and DNA-
PK pathway during adipogenesis.  We chose to study γH2A.X, a marker of DNA damage, 
because it is phosphorylated by ATM and DNA-PK in response to DNA damage (An et al 
2010, B Meyer et al 2013) or oxidative stress (Wrann et al 2013). 
Because our previous experiments demonstrated that ATM and DNA-PK are critical 
for adipocyte differentiation, most likely through an ATM- DNA-PK- ROS dependent 
pathway, γH2A.X expression was the most logical mechanistic candidate to carry out and 
relay/amplify the oxidative stress signaling.  ATM and DNA-PK inhibition is altered by 
prooxidants and antioxidants and γH2A.X phosphorylation is known to occur during 
oxidative stress (Zhao et al 2008) and during to hypoxia (Trayhurn 2013). Both are 
common in adipose tissue of obese individuals.  Taken together, these facts make it 




Differentiated 3T3-L1 fibroblasts were treated with the ATM inhibitor KU 55933 
or the DNA-PK inhibitor NU 7026, as well as antioxidants, and cultured in both 3% and 
20% oxygen incubator environments.  Lipid accumulation and γH2A.X signals were 
detected using immunofluorescence microscopy.   The results suggest that γH2A.X 
phosphorylation is a required step in adipogenesis and that cells in the 20% oxygen 
environment were more prone to oxidative DNA damage and have decreased lipid 
accumulation (See Figure 15: DNA damage in adipocytes) 
In addition, cells treated with the ATM inhibitor, KU 55933, had more γH2A.X 
foci than those treated with the DNA-PK inhibitor, NU 7026.  From literature, it is known 
that γH2A.X and DNA-PK activity display unusual and unexpected activity during 
adipogenesis (Meulle et al 2008). However, the question lies in why there is an increased 
presence of γH2A.X in differentiated cells treated with an antioxidant or those treated with 
























Figure 15: DNA damage in adipocytes 
3T3-L1 fibroblasts were differentiated and treated with the ATM inhibitor, KU 55933, (10 µM in DMSO; 48 h treatment started day 0 
of adipogenesis) or the DNA-PK inhibitor, NU 7026, (10 µM in DMSO; 48 h treatment started day 0 of adipogenesis) and cultured in 
20% oxygen (A) or 3% oxygen (B).  Differentiated cells were then hybrized with a γH2A.X antibody (1: 250 in BSA, 1 h RT; 2° Ab 
Alexa Fluor 488-conjugated goat anti-mouse 1: 200 in BSA, 1 h RT), which is a marker for DNA damage, and LipidTOX (1: 100 in 
BSA, 1 h RT)  then  visualized (DAPI, blue color, nuclear stain; GFP, green color, lipid droplet stain; DsRed, red color, γH2A.X) using 















Preadipocyte senescence is toxic to adipose tissue 
Increased oxidative stress may cause preadipocytes to senescence (Tchkonia, et al. 
2010).  Furthermore, senescent preadipocytes may create a toxic environment that 
contributes to and exacerbates adipocyte dysfunction, paving the way for insulin resistance 
and type 2 diabetes (Guilherme, et al. 2008).  It is our hypothesis that ATM and DNA-PK 
kinases have a role in the propagation of senescent preadipocytes (Please refer to Figure 
27: Conceptual Model for more details).   
In order to test this hypothesis, we treated undifferentiated 3T3-L1 cells with the ATM 
kinase inhibitor KU 55933 or DNA-PK kinase inhibitor NU 7026.  We observed a 
senescent-like phenotype in the cells (See Figure 16: ATM and DNA-PK kinase inhibition 
causes a senescent-like phenotype).  Not only was the phenotype of the preadipocytes 
affected, but an increased presence of SA-β-gal was more detected in cells treated with 
DNA-PK kinase inhibitor, NU 7026 and ATM kinase inhibitor, KU 55933, and the general 
PIKK inhibitors wortmannin and caffeine, than cells with no treatment at all (See Figure 
17: ATM and DNA-PK inhibition cause preadipocyte senescence). 
We experimented with a co-culturing preadipocytes and adipocytes to see if the 
extracellular environment of one could illicit cellular changes in the other. Preadipocytes 
have functions beyond serving as a reservoir for adipogenesis.  During adipose tissue 
dysfunction preadipocytes can behave like macrophages and participate directly in 
inflammatory processes (Cousin, et al. 1999).   
Differentiated 3T3-L1 adipocytes were co-cultured with preadipocytes treated with 
the ATM kinase inhibitor, KU 55933, or the DNA-PK kinase inhibitor, NU 7026, to assess 




adipocytes.  The differentiated adipocytes and the senescent preadipocytes were co-
cultured for 72 hours, then measured for lipid accumulation.  The most apparent phenotype 
of the differentiated 3T3-L1 cell was a diminished scheme of lipid accumulation.  
Additionally, the cells took on different shapes from their normal adipocyte counterparts 














Figure 16: ATM and DNA-PK kinase inhibition causes a senescent-like phenotype 
Undifferentiated 3T3-L1 cells (preadipocytes) (A) were treated with the ATM kinase inhibitor KU 55933 (10 µM dissolved in DMSO, 6 days) (B) or the DNA-PK kinase inhibitor 
NU 7026 (10 µM dissolved in DMSO, 10 days) (C) then harvested for analysis.  Cells were observed with a fluorescence microscope to observe LipidTOX staining (GFP, green 
















Figure 17: ATM and DNA-PK inhibition cause preadipocyte senescence 
Undifferentiated 3T3-L1 cells (preadipocytes) were treated with the ATM kinase inhibitor KU 55933 (10 µM dissolved in DMSO, 48 h), the DNA-PK kinase inhibitor NU 7026 (10 
µM dissolved in DMSO, 48 h) and the general PIKK inhibitors caffeine (2 mM in dd H2O) and wortmannin (200 µM in DMSO) then allowed to recover for 10 days.  Cells were 














Figure 18: Senescent preadipocytes alter phenotype of adipocytes in co-culture model 
Undifferentiated 3T3-L1 fibroblasts were grown on porous wells and made to senescence with the ATM inhibitor, KU 55933, (10 µM in DMSO; continuous) or the DNA-PK 
inhibitor, NU 7026, (10 µM in DMSO; continuous) and cultured in 20% oxygen (not shown).  The well containing cells treated with KU 55933 was transferred to a culture of 
differentiated 3T3-L1 cells (B) and the well containing cells treated with NU 7026 was transferred to a different culture of differentiated 3T3-L1 cells (C).  The differentiated cells 
and senescent preadipocytes were co-cultured together for 72 h, then the adipocytes were harvested and stained with LipidTOX (1: 100 in BSA, 1 h RT, green color) and mounted 
on slides containing DAPI (1 drop, nuclear stain, blue color) then visualized using an immunofluorescent microscope (63x oil-immersion) and compared to differentiated 3T3-L1 






Our results support the hypothesis that ROS, oxidative stress, and senescence can play 
a central role in metabolic dysfunction (Nelson, et al. 2012) and that the kinases ATM and 
DNA-PK are key orchestrators of this response. Furthermore, this study helps elucidate 
possible mechanisms whereby preadipocytes and adipocytes cause dysfunctions in adipose 
tissue during obesity.   
We believe our results help explain why, during obesity, it is possible that 
preadipocytes do not or cannot normally replicate and only undergo partial adipogenesis, 
giving rise to non-functional, immature adipocytes.  This could increase local and systemic 
inflammation, resulting in infiltration by macrophages (O'Rourke, et al. 2012, Trayhurn 
and Wood 2004).  
The increase in H2A.X phosphorylation in differentiated adipocytes can be explained 
by a recent study that indicates high levels of phosphorylation of H2A occurs after mitotic 
arrest in normal cells (Tu et al 2013).  Preadipocytes have to undergo mitotic arrest before 
committing to the adipocyte linage, so perhaps H2A phosphorylation by ATM and/or 
DNA-PK in response to oxidative stress is a key event in mitotic clonal expansion.  If that 
were the case, it would also help explain why preadipocytes that have ATM and DNA-PK 
inhibited fail to undergo full differentiation.  Further studies are needed to confirm these 
hypotheses. 
Recently, the role of dysfunctional beta-cells has been tied closely with the diabetic 
state (Bensellam et al 2012, Gilbert and Liu 2012).  Beta- cells primarily self-replicate and 




are critical to ensuring proper replication and function of beta-cells (Tavana and Zhu 2011).  
The DNA damage proteins ATM and DNA-PK are key regulators of the cell cycle and are 
involved in checkpoint activation (Lisby et al 2004, Zhou and Elledge 2000), so they may 
play a large role in protecting beta-cells. 
  Although our study was not done in beta-cells, we show that disrupted DNA damage 
signaling in adipocytes causes incomplete differentiation  and decreased lipid 
accumulation, both factors which contribute to type 2 diabetes and metabolic dysfunctions 
(Alves et al 2010, Guilherme, et al. 2008, Ravussin and Smith 2002, Scherer 2006).  
Furthermore, phosphorylation of histone 2A, a common marker of DNA damage, is 
greatest in differentiated adipocytes (See Figure 15: DNA damage in adipocytes), 
suggesting that the DNA damage response may play a necessary role during adipogenesis 




CHAPTER 3: THE EFFECT OF SELENIUM SPECIES ON 
ADIPOGENESIS IS ORCHESTRATED BY OXIDATIVE 
STRESS AND INVOLVES DNA DAMAGE RESPONSE 
PROTEINS 
Abstract 
We have shown that the DNA damage response proteins ATM and DNA- PKcs, 
members of the PI(3)K family of serine/threonine kinases, are activated in response to 
oxidative stress in normal human fibroblasts.  This protein family is implicated in insulin-
stimulated glucose uptake.  We manipulated the differentiation of murine 3T3-L1 
preadipocytes and mouse embryonic fibroblasts employing chemical inhibitors of ATM 
and DNA- PKcs exposed to pharmacological levels of insulin.  We also tracked the 
phosphorylation patterns of ATM and DNA- PKcs after selenium treatment to examine 
DNA damage responses in adipocytes.  ATM and DNA- PKcs were both activated in 
response to selenium treatments in differentiated adipocytes.  Taken together, selenium’s 
involvement in adipogenesis is dependent on oxidative stress pathways that may be 
mediated by DNA damage response proteins. 
Introduction 
Obesity is a worldwide concern, especially in the westernized world.  Molecular 
studies done to elucidate the pathways that lead to and maintain obesity have yet to provide 




targets for obesity prevention and treatment is adipocyte differentiation; the process by 
which precursor cells become committed specialized cells that store triglycerides.  Obesity 
is not only a burden financially, emotionally and socially; it predisposes individuals to a 
range of health problems, such as diabetes and metabolic syndrome.  The loss of glucose 
homeostasis is the hallmark of diabetes mellitus, a metabolic disease caused by impaired 
tissue responsiveness to insulin or by decreased pancreatic insulin secretion.  
Selenium can act as an insulin mimetic (Ezaki 1990, Heart and Sung 2001, Heart and 
Sung 2003, Hwang et al 2007).  Most diabetics have elevated serum selenium.  (Bleys et 
al 2007a, Bleys et al 2007b, Ezaki 1990).  However, selenium pretreatment protects 
hepatocytes against damage from drug-induced diabetes in rats (Can et al 2005).  The only 
irrefutable evidence in the literature about selenium’s relationship with diabetes is that high 
selenium status is positively associated with diabetes, with the exception of pregnant 
women (Farhat et al 1993, Farhat et al 1995, Tan et al 2001).  Selenium supplements are 
not recommended for the prevention of diabetes.   
 Murine 3T3-L1 preadipocyte cells are one of the most commonly used models to 
study obesity, metabolic disease and diabetes.  Confluent 3T3-L1 preadipocytes 
differentiate to adipocytes in the presence of insulin, dexamethasone and 
isobutylmethylxanthine.  We hypothesized that selenium treatment will alter adipogenesis 






Cell lines and maintenance  
Cells were grown.  Murine 3T3-L1 preadipocytes (CL173) were purchased from 
American Type Culture Collection  (Manassas, VA) and cultured in Dulbecco’s minimum 
essential medium (DMEM) (GibcoBRL, Carlsbad, CA) as previously reported (Rocourt, 
et al. 2013, Zhang, et al. 2011).  The media was supplemented with 10% fetal bovine serum 
(FBS) (GibcoBRL) and 1% penicillin/streptomycin (GibcoBRL) and were maintained in a 
37° C humidified atmosphere in either 20% oxygen. 
Adipocyte differentiation 
Adipogenesis was induced by using media (Hemati, et al. 1997) supplemented with 
10% FBS DMEM.  The media was then supplemented with the hormonal proadipogenic 
cocktail of 166 nM insulin dissolved in 0.02 M HCl, 0.5 mM 3-isobutyl-1-methyl-xanthine 
(IBMX) dissolved in 0.5N potassium hydroxide (KOH) and 1 µM dexamethasone (Dex) 
dissolved in ethanol to cells that were two days past 100% confluency (designated Day 0).  
After two days, the MDI media was refreshed for 1 day and then the cells were maintained 
in insulin media (166 nM insulin in 10% FBS DMEM) until used for experiments, typically 
on day 12~15  (See Figure 1: Timeline of Adipocyte Differentiation). 
Treatments 
For differentiation and immunofluorescence assays, 3T3-L1 cells were treated with, 
without or in combination with the following chemicals; 2 μM sodium selenite (Na2SeO3) 
in PBS (Sigma-Aldrich, St. Louis, MO), 2 μM methylseleninic acid, 95% (MSeA) in PBS 




(Tocris),  500 μM paraquat in double distilled water (Sigma-Aldrich), 1 mM hydroxyurea 
(HU) in double distilled water (MP Biomedicals, Santa Ana, CA).  All chemicals were 
added to cell culture for the indicated times and at the indicated concentrations and 
incubated at 37 °C.  Please refer to the appendix for more detailed information. 
Oil-Red-O staining 
Oil-Red-O  (ORO) (Sigma-Aldrich, St. Louis, Missouri) staining was conducted, as 
previously described (Ramirez-Zacarias, et al. 1992, Ross, et al. 1999, Ross, et al. 2000, 
van Goor, et al. 1986) with little modification, in order to determine lipid accumulation. 
Dye preparation: 0.5 g of ORO was dissolved in 250 mL isopropanol to form a stock 
solution.  30 minutes before staining, 20 mL of deionized water was added to 30 mL of the 
stock solution to make the working solution, and then put on stir plate at 50° C until 
adipocyte staining.  Cell staining:  Adherent cells were gently rinsed with phosphate-
buffered saline (PBS) then fixed in a 4% paraformaldehyde solution for 1 h, washed with 
1x PBS then refixed with 4% paraformaldehyde solution for 2-3 days.  After fixation, the 
cells were rinsed with 1x PBS followed by 60% isopropyl alcohol, which was added and 
allowed to evaporate.  The cells were then stained with the ORO working solution for 10 
min.  Plates were rinsed 3x with tap water and allowed to dry.  Photographs were taken, 
and cells were subsequently analyzed as described below.  Quantification of stained cells: 
Stained cells were counted under a light microscope (40x- 400x magnification) and given 
a score based on the percent lipid accumulation when compared to the differentiated 




Coverslip preparation  
Immunofluorescence analysis was performed as described previously with only minor 
modification (Nioi, et al. 2007, Rocourt, et al. 2013)_ENREF_9.  3T3-L1 cells were seeded 
on coverslips in 6-well plates at 70% confluency then differentiated and treated as 
described above.  At the end of the experiment, coverslips were rinsed in PBS, fixed in 4% 
paraformaldehyde solution in PBS for 30 min at room temperature and then washed twice 
with 1x PBS.  
Antibody detection   
Cells were prepared as described above with minor modifications as follows; after 15 
min fixation with a paraformaldehyde solution, the cells were permeabilized with ice-cold 
methanol for 10 min at -20° C.  Next, the cells were permeabilized again for 10 min in 
0.3% Triton X-100 and then blocked in 10% normal goat serum / 0.3 M glycine in 1x PBS 
for 1 h to block non-specific protein-protein interactions.  Individual coverslips were 
hybridized with either of the following antibodies for 1 h at room temperature (RT): 
phospho-DNA-PKcs Thr-2647 (lot 903801) (1: 250 in BSA, Abcam, and Boston, MA) and 
phospho-ATM Ser-1981 (lot 20772) (1:250 in BSA, Rockland, Gilbertsville, PA).  After 
incubation with antibodies, the coverslips were washed in 1x PBS, and incubated with the 
appropriate secondary antibodies (Alexa Fluor 488-conjugated goat anti-rabbit for 
phospho-DNA-PKcs Thr-2647 and Alexa Fluor 594-conjugated goat anti-mouse for 
phospho-ATM Ser-1981 both from Invitrogen Molecular Probes, Carlsbad, CA) in BSA 




coverslips were mounted onto slides that contained a drop of DAPI and were visualized 
using immunofluorescent microscopy. 
Quantification of antibody data 
Immunostaining was visualized using the 63x oil-immersion lens on a Zeiss Axio 
Observer Z1m (Zeiss, Thornwood, NY) and analysis was performed as described (Rocourt, 
et al. 2013, Wu, et al. 2010).  A z-stack of 10 photos was taken of three random areas on 
each cover slip using the appropriate channels (DAPI, GFP and DsRed).  Images were 
obtained using the same parameters of brightness, contrast and exposure time and were 
processed using the deconvolution function of the software AxioVision Release 4.7.2.0.   
Statistics 
All the experiments were independently performed and repeated three times.  We 
defined the control as differentiated 3T3-L1 or MEF cells, induced to undergo adipogenesis 
as described above unless stated otherwise in the text.  The data were analyzed using 
GraphPad Prism software version 5.04 (GraphPad Software Inc., La Jolla, California).  
Two tailed, one- sample t-tests were applied to determine statistical significance (*, 
p<0.05) between treatments.   
Results 
Selenium speciation differentially effects lipid accumulation 
In order to investigate the suspected insulin-mimetic effect of selenium  (Heart and 
Sung 2003, Xu et al 2011)  on adipocyte differentiation and lipid accumulation, cells were 




the differentiation process (See Figure 1: Timeline of Adipocyte Differentiation for 
timeline and day designation).   
Interestingly, the amount of lipid accumulation and adipocyte differentiation were 
found to be dependent on the selenium species used.  We found that Na2SeO3 treatment 
decreased lipid accumulation when added at the initiation of hormone induction (See 
Figure 19: Sodium selenite treatment decreases lipid accumulation when added at the start 
of adipogenesis ) and that MSeA treatment slightly increased 3T3-L1 differentiation when 
added at the start of adipogenesis, as well as when added after the initial hormone exposure 
period (See Figure 20: Methylseleninic acid promotes lipid accumulation).    
Furthermore, both species of selenium elicited maximal effects on lipid accumulation 
when they were added after the standard hormonal induction period.  This response 
indicates that the insulin-mimetic effect of selenium is observed only following the 
commitment to adipocyte lineage.  Therefore, the effects of selenium treatment during 
adipocyte differentiation are likely explained by properties of selenium that are not related 

























Figure 19: Sodium selenite treatment decreases lipid accumulation when added at the start of adipogenesis  
3T3-L1 fibroblasts were differentiated and treated with Na2SeO3, (2 µM in PBS, continuous treatment beginning either on day 0 or 3 of adipogenesis) and cultured in 20% oxygen.  
Lipid accumulation was determined by Oil-Red-O staining and analyzed using a light microscope (400x).  Each treatment was given a score based on the percent Oil-Red-O saturation 
when compared to the differentiated control, which we designated to be 100%.  Values are means ± S.E.M. (n= 3; * denotes significance (p<0.05) as compared to differentiated 3T3-
























Figure 20: Methylseleninic acid promotes lipid accumulation throughout adipogenesis  
3T3-L1 fibroblasts were differentiated and treated with methylseleninic acid, (2 µM in PBS, continuous treatment beginning either on day 0 or 3 of adipogenesis) and cultured in 
20% oxygen.  Lipid accumulation was determined by Oil-Red-O staining and analyzed using a light microscope (400x).  Each treatment was given a score based on the percent Oil-
Red-O saturation when compared to the differentiated control, which we designated to be 100%.  Values are means ± S.E.M. (n= 3; * denotes significance (p<0.05) as compared to 




The role of DNA damage kinases in a selenium treated adipocyte model 
Because of the unique observations that lipid accumulation is dependent on the DNA 
damage kinases ATM and DNA-PK, and that selenium species affects lipid accumulation 
during adipogenesis, we aimed to determine whether this response to selenium species 
occurs via the ATM or DNA-PK pathways.  To address this question, the kinase activity 
of ATM and DNA-PK in 3T3-L1 cells were chemically inhibited using the commercially 
available inhibitors KU 55933 for ATM inhibition and NU 7026 for DNA-PK inhibition.  
The cells were then challenged with sodium selenite and lipid accumulation measured by 
ORO staining. 
Sodium selenite treatment significantly reduced lipid accumulation in cells treated 
with the ATM inhibitor (See Figure 21: Sodium selenite further decreases lipid 
accumulation in ATM inhibited cells). Sodium selenite reduced lipid accumulation in cells 
that have had DNA-PK inhibited, although analysis revealed the observation was not 
statistically significant (See  
Figure 22: Sodium selenite slightly reduces lipid accumulation in DNA-PK inhibited 
cells).  Taken together, these results suggest that the effect of sodium selenite on lipid 
accumulation occurs through an ATM-dependent pathway, with ATM located upstream of 
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Figure 21: Sodium selenite further decreases lipid accumulation in ATM inhibited cells 
Differentiated 3T3-L1 fibroblasts were treated with the ATM inhibitor, KU 55933, (10 µM in DMSO; 48 h treatment started day 0 of adipogenesis) and Na2SeO3 (2 µM in PBS; 48 
h treatment started day 0 of adipogenesis) and cultured in 20% oxygen.  Lipid accumulation was determined by Oil-Red-O staining and analyzed using a light microscope (400x).  
Each treatment was given a score based on the percent Oil-Red-O saturation when compared to the differentiated control, which we designated to be 100%.  Values are means ± 
S.E.M. (n= 3; * denotes significance (p<0.05) as compared to differentiated 3T3-L1 cells, # denotes significance (p<0.05) as compared to differentiated 3T3-L1 cells with ATM 
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Figure 22: Sodium selenite slightly reduces lipid accumulation in DNA-PK inhibited cells 
Differentiated 3T3-L1 fibroblasts were treated with the DNA-PK inhibitor, NU 7026, (10 µM in DMSO; 48 h treatment started day 0 of adipogenesis) and Na2SeO3 (2 µM in PBS; 
48 h treatment started day 0 of adipogenesis) and cultured in 20% oxygen.  Lipid accumulation was determined by Oil-Red-O staining and analyzed using a light microscope (400x).  
Each treatment was given a score based on the percent Oil-Red-O saturation when compared to the differentiated control, which we designated to be 100%.  Values are means ± 




Selenium species restores lipid accumulation in cells challenged with known DNA 
stressors 
Cells treated with paraquat (500 µM, 48 h) during differentiation failed to survive.  
We suspect that the cause of death of these cells (apoptosis, necrosis, autophagy etc.) was 
most likely due to the high oxidative stress burden.  When cells were co-treated with 
sodium selenite, there were no effects on lipid accumulation and cell survival.  However, 
when cells were exposed to methylseleninic acid, we were able to prevent cell death and 
restore lipid accumulation (See Figure 23: Methylseleninic acid, but not sodium selenite, 
restores lipid accumulation in paraquat treated cells). 
The treatment of cells with HU (1 mM, 48 h) treatment decreased lipid accumulation, 
which in in vivo models, is a unifying symptom for lipid dystrophies.  HU treated 
adipocytes co-treated with either sodium selenite or methylseleninic acid promoted an 
increase in lipid accumulation (See Figure 24: Selenium reverses the effect of hydroxyurea 
on adipogenesis), confirming the role of selenium in restoring lipid accumulation in cells 
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Figure 23: Methylseleninic acid, but not sodium selenite, restores lipid accumulation in paraquat treated cells 
Differentiated 3T3-L1 fibroblasts were treated for 48 h starting at day 0 of adipogenesis with the ROS generator paraquat (500 µM in dd H2O), Na2SeO3 (2 µM in PBS), MSeA (2 
µM in PBS) and cultured in 20% oxygen.  Lipid accumulation was determined by Oil-Red-O staining and analyzed using a light microscope (400x).  Each treatment was given a 
score based on the percent Oil-Red-O saturation when compared to the differentiated control, which we designated to be 100%.  Values are means ± S.E.M. (n= 3; * denotes 
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Figure 24: Selenium reverses the effect of hydroxyurea on adipogenesis 
Differentiated 3T3-L1 fibroblasts were treated for 48 h starting at day 0 of adipogenesis with the replication stress inducer hydroxyurea (HU) (1 mM in dd H2O), Na2SeO3 (2 µM in 
PBS), MSeA (2 µM in PBS) and cultured in 20% oxygen.  Lipid accumulation was determined by Oil-Red-O staining and analyzed using a light microscope (400x).  Each treatment 
was given a score based on the percent Oil-Red-O saturation when compared to the differentiated control, which we designated to be 100%.  Values are means ± S.E.M. (n= 3; * 





The role of the selenium induced DNA damage response during adipogenesis 
In order to determine the activation of the ATM kinase during adipogenesis, ATM 
kinase activation was assessed.  We measured the anti-pATM Ser-1981 antibody, and 
DNA-PK activation, as indicated by the anti- pDNA-PKcs Thr-2647 antibody.  The latter 
phosphorylation site was selected because it is known to be downstream of ATM in the 
DNA damage response (Chen et al 2007).  Phosphorylation at Thr-2647 is required for 
cellular resistance to radiation (Soubeyrand et al 2003) and promotes the repair of DNA 
double strand breaks by the NHEJ pathway (Povirk et al 2007).   
The acid and salt forms of selenium activated pATM Ser-1981 (See Figure 25: 
Selenium treatment is a potent activator of the ATM kinase during adipogenesis) but not 
pDNA-PKcs Thr-2647 (See Figure 26: Selenium induced phosphorylation of DNA-PKcs at 
Thr-2647 is downstream of ATM kinase).  However, sodium selenite treatment results in 
statistically significant increased phosphorylation of ATM at Ser-1981 than 
methylseleninic acid treatment.  These results were expected based on the metabolism and 
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Figure 25: Selenium treatment is a potent activator of the ATM kinase during adipogenesis 
Cells were treated with, without or in combination with KU 55933 (10 µM), Na2SeO3 (2 µM) or MSeA (2 µM) at the time of induction with MDI media.  Cells were maintained in 
insulin media for five days, then fixed, probed for total ATM and pATM Ser-1981 and then visualized using AxioVision software.  Values are means ± S.E.M. (n= 3; * denotes 
significance (p<0.05) as compared to differentiated 3T3-L1 cells, # denotes significance (p<0.05) as compared to differentiated 3T3-L1 cells treated with Na2SeO3 only, & denotes 
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Figure 26: Selenium induced phosphorylation of DNA-PKcs at Thr-2647 is downstream of ATM kinase   
Cells were treated with, without or in combination with KU 55933 (10 µM), Na2SeO3 (2 µM) or MSeA (2 µM) at the time of induction with MDI media.  Cells were maintained in 
insulin media for five days, then fixed, probed for total DNA-PKcs and pDNA-PKcs Thr-2647 and then visualized using AxioVision software. Values are means ± S.E.M. (n= 3; * 
denotes significance (p<0.05) as compared to differentiated 3T3-L1 cells, # denotes significance (p<0.05) as compared to differentiated 3T3-L1 cells treated with Na2SeO3 only, & 
denotes significance (p<0.05) as compared to differentiated 3T3-L1 cells treated with MSeA, and $ denotes significance (p<0.05) as compared to differentiated 3T3-L1 cells treated 






Selenium has both insulin (Ezaki 1990) and non-insulin (Heart and Sung 2003) like 
actions in adipocytes. These help to explain this process on a molecular level and could 
account for the protective effect of selenium in diabetic animals.  Selenium has altered 
function and status in disease states; particularly diabetes (Ammar et al 2004, Ayaz et al 
2002, Ayaz et al 2004, Ayaz and Turan 2006, Battell et al 1998, Bleys, et al. 2007b, 
Brajovic et al 1987, Can, et al. 2005, Douillet et al 1996, He et al 2009, Kilinc et al 2008, 
Laclaustra et al 2009, Marcason 2008, Mueller et al 2009, Sheng et al 2004, Soska and 
Kunert 2004, Stranges et al 2007, Vinceti et al 2009, Yadav et al 1991), cardiovascular 
disease (Agbor et al 2007, Laclaustra, et al. 2009, Rajpathak et al 2005, Soska and Kunert 
2004, Toyran et al 2005, Turan et al 2005) and obesity (Douillet et al 1998, Gjorup et al 
1988, Kanarek and Aprille 1986, Maquoi et al 2002, McClung et al 2004). 
The results of the study agree with  others in the literature who have found that 
selenium is an insulin mimetic (Ezaki 1990).  However, we go further and show that 
selenium speciation is a critical factor in the insulin promoting effect of selenium. Both 
forms of selenium preferentially targeted sites on ATM as opposed to DNA-PKcs.  In 
addition, sodium selenite was more potent than the acid form of selenium in stimulating 
phosphorylation of ATM at Ser-1981 and DNA-PKcs at Thr-2647.  We hypothesized that, 
because sodium selenite is more effective in generating ROS than the acid form, more sites 
were activated.   
  Paraquat, a herbicide, is an inducer of ROS and is a known toxicant (Ali et al 1996, 
Ross et al 1979).  The damage from paraquat toxicity is processed via the selenium 




homozygous null mutations for GPX1 have a higher susceptibility to paraquat (de Haan et 
al 1998).  We hypothesized that selenium may have beneficial effects on lipid accumulation 
in 3T3-L1 cells that were exposed to DNA stressors, such as paraquat or hydroxyurea 
(HU), because of the protective role of selenium in antioxidant defenses that guard against 
genome instability.   
HU inhibits DNA synthesis and cellular proliferation but does not inhibit protein or 
RNA synthesis (Sinclair 1965, Young and Hodas 1964).  Specifically, HU is a 
ribonucleotide reductase inhibitor (Elford 1968) that has antineoplastic properties, making 
it a popular chemotherapy drug (Nocentini 1996, Shao et al 2006).  HU is a widely used 
reagent in studies investigating DNA damage response due to its ability to stall DNA 
replication by depleting cellular deoxyribonucleotide pools (Reichard 1988).  This 
depletion activates the DNA damage response (Lisby, et al. 2004, Zhou and Elledge 2000).  
Interestingly, HU can induce both gene expression and synthesis of proinflammatory 
cytokines, such as TNF-α and IL-6 (Navarra et al 1997).  Both cytokines are known to be 
increased during obesity related complications (Trayhurn and Wood 2004).  
We were able to reverse the effects of HU on adipocyte differentiation.  We found 
that when we treated preadipocytes with HU on induction day there was a significant 
decrease in differentiation.  When we co-treated the cells with both forms of selenium we 
rescued the cells and a larger percentage of preadipocytes became mature adipocytes.   
HU is a popular treatment for sickle cell disease because it inhibits the polymerization 
of sickle hemoglobin by increasing the synthesis of fetal hemoglobin and can prolong the 
lifespan of the individual (Charache 1997, Steinberg et al 2003). HU treatment increases 




et al 2010).  Increased GPX1 could possibly explain the effectiveness of HU in sickle cell 
patients.  This suggests that HU may have a direct interaction with selenium, supporting 
our data that shows an interaction between selenium and HU.   
We showed that there is a significant increase in lipid accumulation in HU treated 
cells following selenium treatment.  This data, and the similar findings from the paraquat 
treated cells, suggest that selenium co-treatment could reverse or decrease lipodystrophies 
and cachexia that commonly occur because of medications used to treat chronic diseases 
such as sickle cell, cancer, AIDS and other wasting diseases.  These results could also 
support the fact that supranutritional levels of selenium could reverse HU’s intended effects 
and render it useless for chemotherapy patients. 
In the future, we hope to describe the mechanism of selenium and DNA damage 
response in the differentiation of adipocytes and elucidate how these things affect the 









CHAPTER 4: SUMMARY AND CONCLUSIONS 
Summation of Objectives  
The first objective was to understand if ATM and DNA-PK kinase inhibition have an 
effect on adipocyte integrity during adipogenesis and throughout the lifespan of the 
adipocyte.  This objective was met by confirming the role of ATM and DNA-PK kinase 
activity during adipogenesis and by demonstrating that their role was directly dependent 
on intracellular ROS levels. 
The second objective was to understand how ATM and DNA-PK maintain adipocyte 
and preadipocyte integrity by preventing some of the associated senescent properties of 
damaged cells.  We have found that inhibition of ATM and DNA-PK kinase activity causes 
a senescent-like phenotype in preadipocytes. 
We believe the senescent preadipocyte is the foundation for the impaired adipogenesis 
and unusual adipocyte phenotype we see after stimulation of adipogenesis in cells that have 
ATM and DNA-PK inhibited.  We propose that ATM and DNA-PK inhibition in 
preadipocytes causes cellular senescence and prevents the cells from undergoing complete 
adipogenesis, even after the standard pro-adipogenic hormonal treatment (See Figure 1: 
Timeline of Adipocyte Differentiation). 
It is possible that by inhibiting ATM and DNA-PK in preadipocytes, we have induced 
senescence and consequently created a model for studying adipocyte dysfunction.  Our 
study can help comprehend how adipocyte dysfunction is triggered and maintained, and 




consequences of adipocyte dysfunction, which would help address and treat the 
comorbidities associated with obesity.   
Furthermore, we propose a ROS-driven hypothesis of how ATM and DNA-PK 
inhibition contribute to dysfunctional adipocytes.  After inhibiting enzymes that respond 
to and regulate ROS, what we believe we have done is induced a preadipocyte environment 
with high/discordant oxidative stress levels.  Our studies suggest that if increased ROS in 
dysfunctional adipocytes can be regulated, the consequences of adipose tissue dysfunction 
can be prevented or treated.  
The third objective was to understand how nutrients could affect adipogenesis, 
particularly by using selenium to manipulate the ROS-ATM-DNA-PK dependent 
adipogenic pathway.  Interestingly, it was found that selenium speciation was a key factor 
in altering lipid accumulation, most likely due to differences in redox potentials of 
selenium metabolites.  Therefore, adding more complexity to weight maintenance theories 
that rely on strict calorimetery rules.   
Significance 
Obesity is a worldwide health epidemic that contributes to and exacerbates many 
disease states (See Metabolic Dysfunctions).  Current treatment strategies for treating 
obesity and its complications have failed.   Understanding normal adipose tissue 
metabolism, physiology and differentiation could be a foundation for obesity research and 
a cornerstone to develop therapeutic interventions.  We believe that there is a critical gap 
in our knowledge of how dysfunctional adipocytes are propagated (See Mechanisms of 




induced disease states might be possible.  The work summarized in this dissertation is 
presented in the hope to be able to help guide current therapeutic strategies and identify 
molecular targets for the treatments of the comorbidities of obesity.   
Often times in obese individuals, particularly those with metabolic diseases, there is 
increased oxidative DNA damage (Al-Aubaidy and Jelinek 2011) which may lead to 
genomic instability (Ahima 2009), thus perpetuating the chronic disease cycle.  This 
inflammatory state might directly affect beta-cell homeostasis and disrupt self-replication, 
causing hyper- and hypoplasia of beta-cells thereby driving the type 2 diabetic phenotype. 
In our research, we believe dysfunctional preadipocytes, perhaps caused by these 
cytokines, activate the innate immune system creating the subclinical inflammatory 
response indicative of type 2 diabetes, that go on to induce insulin resistance and 
hyperglycemia (See Figure 27: Conceptual Model). 
Our research further elucidates the management of oxidative stress as a key factor to 
maintain adipocyte tissue homeostasis in order to prevent metabolic dysfunctions.  Further 
research is required to elucidate the mechanisms by which adipocytes maintain 
homeostasis within the body and whether adipose disequilibrium causes or contributes to 





Figure 27: Conceptual Model 




Adipocyte dysfunction includes increased lipolysis, impairment of triglyceride 
storage and increased cytokine production (Coppack 2001). All of these are linked to 
insulin resistance (de Heredia et al 2012).  It is clear that there is an excess production of 
IL-6 and TNFα in type 2 diabetes. However, the origins, order of events, and molecular 
mechanisms linking these cytokines to type 2 diabetes are not well understood or defined.  
IL-6 and TNFα stimulate the production of acute phase proteins (James, et al. 2001, Ogden, 
et al. 2006) that then cause inflammation.  Since inflammation is a common facet that most 
metabolic diseases related to obesity share (Candore et al 2010, Emanuela et al 2012, 
Fuentes et al 2013, Kitade et al 2012, Sun, et al. 2012, Ye 2013), understanding how 
cytokines promote immune system imbalance is critical in the prevention and treatment of 
the comorbidities of obesity.   
We have attempted to elucidate how obesity can promote conditions that favor chronic 
disease on the molecular level by studying DNA damage response proteins in adipocytes.  
The work summarized here represents the initial investigation of the roles of ATM and 
DNA-PKcs in the formation and maintenance of adipocytes.  In particular, we show that 
maintenance of oxidative tone via the ATM and DNA-PK pathway is necessary to promote 
lipid accumulation in adipocytes.  Moreover, our work helps to explain the importance of 
balancing oxidative stress in order to maintain normal adipose tissue function and thus 
stifle the onset or progression of some of the comorbidities of obesity (See Linking 
Metabolic Derangements to Adipocytes).  These findings portray a novel approach to 
addressing the comorbidities of obesity and attempt to provide insight that could improve 
the quality of life for overweight and obese individuals and to help understand the evolution 





Cell Culture Reagents 
• 1% penicillin/streptomycin (GibcoBRL, Carlsbad, CA, Cat# 15140148) 
• IBMX (Sigma-Aldrich, St. Louis, MO, Cat# I-7018) 
• Dex (Sigma-Aldrich, St. Louis, MO, Cat# D-4902) 
• DMEM (GibcoBRL, Carlsbad, CA, Cat# 11965-084)  
• FBS (GibcoBRL, Carlsbad, CA, Cat# 10099-141) 
• Insulin (Bovine; Sigma-Aldrich St. Louis, MO, Cat#  I-5500) 
• Pen/Strep/Glutamine (100x P/S/G; GibcoBRL, Carlsbad, CA, Cat#10378-016)  
Cell Culture Chemicals and Treatments 
• Caffeine (2 mM, Sigma-Aldrich, St. Louis, MO, Cat# 485635) 
• DMSO (Vehicle, Sigma- Aldrich, St. Louis, MO, Cat# 472301) 
• H2O2 (10 µM, Sigma- Aldrich, St. Louis, MO, Cat# 216763) 
• HU (1mM, MP Biomedicals, Santa Ana, CA, Cat# 0210202301) 
• KU 55933 (10 µM, Tocris, Ellisville, MO, Cat# 3544) 
• MSeA (2 µM, Sigma-Aldrich, St. Louis, MO Cat# 541281) 
• Na2SeO3 (2 µM, Sigma-Aldrich, St. Louis, MO Cat# S9133) 
• NAC (10 mM, Sigma- Aldrich, St. Louis, MO, Cat# A-7250) 
• NU 7026 (10 µM, Tocris, Ellisville, MO, Cat# 2828) 
• Paraquat (500 µM, Sigma-Aldrich, St. Louis, MO Cat# 36541) 
• TEMPO (1 mM, Sigma-Aldrich, St. Louis, MO, Cat# 214000) 





• Alexa Fluor 488-conjugated goat anti-rabbit secondary antibody (1: 200 in BSA, 
Invitrogen, Carlsbad, CA, Cat# A11008) 
• Alexa Fluor 594-conjugated goat anti-mouse secondary antibody (1: 200 in BSA, 
Invitrogen, Carlsbad, CA, Cat# A11005) 
• CM-H2DCFDA (10 µM in PBS, Invitrogen, Carlsbad, California, Cat# C6827) 
• HCS LipidTOX™ (Green neutral lipid stain 1: 100 in BSA, Invitrogen Molecular 
Probes Inc., Carlsbad, CA, Cat# H34475) 
• ORO (0.5 g dissolved in 250 mL isopropanol, Sigma-Aldrich, St. Louis, MO, Cat# 
O0625-100G) 
• pATM Ser-1981, phospho-ATM at Ser-1981  
•  pDNA-PKcs Thr-2647 Antibody (lot # 903801)  (1:200 in BSA, Abcam, Boston, 
MA, Cat# ab61045) 
• Perilipin D418 Antibody (1: 200 in BSA, Cell Signaling Technology, Danvers, 
MA, Cat# 3470) 
• Prolong® Gold mounting media containing 4,6-diamidino-2-phenylindole 
(Prolong® Gold mounting media containing DAPI or DAPI) (1 drop, Invitrogen, 
Carlsbad, CA, Cat# P36930) 
• Senescence-associated β-galactosidase kit (SA- β-gal) (Biovision, Milpitas, CA, 
Cat# k320-620) 





Table 1: Cell culture reagents 
 
Chemical Company Catalog Number Treatment Concentration Treatment Duration 
Alexa Fluor® Anti-
Mouse 
Invitrogen A11005 1:200 1 h, RT 
Alexa Fluor® Anti-
Rabbit 
Invitrogen A11008 1:200 1 h, RT 
Caffeine Sigma 485635 2 mM 48 h 
DAPI Prolong® Gold Invitrogen P36930 1 drop  
Dexamethasone Sigma D-4902 1 µM 48 h 
IBMX Sigma I-7018 0.5 mM 48 h 
Insulin Sigma I-5500 166 nm (1 µg/mL) 
48 h as induction 
media, then constant when 
used for adipocyte 
maintenance 
KU 55933 Tocris 3544 10 µM 48 h 
LipidTOX Invitrogen H34475 1:100 1 h, RT 
NAC Sigma A-7250 10 mM 48 h 
NU 7026 Tocris 2828 10 µM 48 h 
pDNA-PKcs Thr-2647 Abcam ab61045 1:200 Overnight 4° C 
Perilipin D418 Cell Signaling 3470 1:200 1 h, RT 
TEMPO Sigma 214000 1 mM 48 h 
Wortmannin Sigma 95455 200 µM 48 h 
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